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Intercellular propagated misfolding of wild-type Cu/Zn superoxide
dismutase occurs via exosome-dependent and -independent mechanisms
Abstract
Amyotrophic lateral sclerosis (ALS) is predominantly sporadic, but associated with heritable genetic
mutations in 5-10% of cases, including those in Cu/Zn superoxide dismutase (SOD1). We previously showed
that misfolding of SOD1 can be transmitted to endogenous human wild-type SOD1 (HuWtSOD1) in an
intracellular compartment. Using NSC-34 motor neuron-like cells, we now demonstrate that misfolded
mutant and HuWtSOD1 can traverse between cells via two nonexclusive mechanisms: protein aggregates
released from dying cells and taken up by macropinocytosis, and exosomes secreted from living cells.
Furthermore, once HuWtSOD1 propagation has been established, misfolding of HuWtSOD1 can be
efficiently and repeatedly propagated between HEK293 cell cultures via conditioned media over multiple
passages, and to cultured mouse primary spinal cord cells transgenically expressing HuWtSOD1, but not to
cells derived from nontransgenic littermates. Conditioned media transmission of HuWtSOD1 misfolding in
HEK293 cells is blocked by HuWtSOD1 siRNA knockdown, consistent with human SOD1 being a substrate
for conversion, and attenuated by ultracentrifugation or incubation with SOD1 misfolding-specific antibodies,
indicating a relatively massive transmission particle which possesses antibody-accessible SOD1. Finally,
misfolded and protease-sensitive HuWtSOD1 comprises up to 4% of total SOD1 in spinal cords of patients
with sporadic ALS (SALS). Propagation of HuWtSOD1 misfolding, and its subsequent cell-to-cell
transmission, is thus a candidate process for the molecular pathogenesis of SALS, which may provide novel
treatment and biomarker targets for this devastating disease.
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Significance	  Statement:	  Amyotrophic	  lateral	  sclerosis	  (ALS),	  an	  incurable	  motor	  neuron	  disease,	  is	  
associated	  with	  mutation	  and	  misfolding	  of	  the	  Cu/Zn	  superoxide	  dismutase	  (SOD1)	  protein.	  	  Prior	  
studies	  found	  that	  mutant	  misfolded	  SOD1	  can	  convert	  wild-­‐type	  SOD1	  to	  a	  misfolded	  form	  inside	  living	  
cells	  in	  a	  prion-­‐like	  fashion.	  	  We	  now	  report	  that	  misfolded	  wild-­‐type	  SOD1	  can	  be	  transmitted	  from	  cell	  
to	  cell,	  and	  that	  propagated	  protein	  misfolding	  can	  be	  perpetuated.	  	  Misfolded	  SOD1	  transmission	  
between	  cells	  can	  be	  mediated	  through	  release	  and	  uptake	  of	  protein	  aggregates,	  or	  via	  small	  
membrane-­‐bounded	  transport	  vesicles,	  called	  exosomes.	  	  These	  mechanisms	  may	  help	  explain	  why	  
sporadic	  ALS,	  without	  genetic	  mutation,	  can	  spread	  systematically	  from	  region	  to	  region	  in	  a	  progressive	  
manner.	  




Amyotrophic	  lateral	  sclerosis	  (ALS)	  is	  predominantly	  sporadic,	  but	  associated	  with	  heritable	  genetic	  
mutations	  in	  5-­‐10%	  of	  cases,	  including	  those	  in	  Cu/Zn	  superoxide	  dismutase	  (SOD1).	  We	  previously	  
showed	  that	  misfolding	  of	  SOD1	  can	  be	  transmitted	  to	  endogenous	  human	  wild-­‐type	  SOD1	  (HuWtSOD1)	  
in	  an	  intracellular	  compartment.	  	  Using	  NSC34	  motor	  neuron-­‐like	  cells,	  we	  now	  demonstrate	  that	  
misfolded	  mutant	  and	  HuWtSOD1	  can	  traverse	  between	  cells	  via	  two	  non-­‐exclusive	  mechanisms:	  
protein	  aggregates	  released	  from	  dying	  cells	  and	  taken	  up	  by	  macropinocytosis,	  and	  extracellular	  
vesicles	  (exosomes)	  secreted	  from	  living	  cells.	  	  Furthermore,	  once	  HuWtSOD1	  propagation	  has	  been	  
established,	  misfolding	  of	  HuWtSOD1	  can	  be	  efficiently	  and	  repeatedly	  propagated	  between	  HEK293	  cell	  
cultures	  via	  conditioned	  media	  over	  multiple	  passages,	  and	  to	  cultured	  mouse	  primary	  spinal	  cord	  cells	  
transgenically	  expressing	  HuWtSOD1,	  but	  not	  to	  cells	  derived	  from	  non-­‐transgenic	  littermates.	  	  
Conditioned	  media	  transmission	  of	  HuWtSOD1	  misfolding	  in	  HEK293	  cells	  is	  blocked	  by	  HuWtSOD1	  
siRNA	  knockdown,	  consistent	  with	  human	  SOD1	  being	  a	  substrate	  for	  conversion,	  and	  attenuated	  by	  
ultracentrifugation	  or	  incubation	  with	  SOD1	  misfolding-­‐specific	  antibodies,	  indicating	  a	  relatively	  
massive	  “transmission	  particle”	  which	  possesses	  antibody-­‐accessible	  SOD1.	  	  Finally,	  misfolded	  and	  
protease	  sensitive	  HuWtSOD1	  comprises	  up	  to	  4%	  of	  total	  SOD1	  in	  sporadic	  ALS	  patient	  spinal	  cord.	  
Propagation	  of	  HuWtSOD1	  misfolding,	  and	  its	  subsequent	  cell-­‐to-­‐cell	  transmission,	  is	  thus	  a	  candidate	  
process	  for	  the	  molecular	  pathogenesis	  of	  sporadic	  ALS,	  which	  may	  provide	  novel	  treatment	  and	  
biomarker	  targets	  for	  this	  devastating	  disease.	  




Amyotrophic	  lateral	  sclerosis	  (ALS)	  is	  a	  fatal	  neuromuscular	  condition	  that	  afflicts	  as	  many	  as	  1	  out	  of	  
350	  males	  and	  420	  females	  over	  18	  (1).	  In	  ALS,	  degeneration	  of	  upper	  and	  lower	  motor	  neurons	  causes	  
progressive	  muscle	  paralysis	  and	  spasticity,	  affecting	  mobility,	  speech,	  swallowing	  and	  respiration	  (2).	  
Half	  of	  affected	  individuals	  die	  within	  3	  years,	  and	  less	  than	  20%	  survive	  for	  more	  than	  5	  years	  (3).	  90-­‐
95%	  of	  cases	  are	  sporadic	  (SALS)	  in	  which	  some	  apparently	  facilitating	  gene	  mutations,	  such	  as	  ataxin-­‐2	  
repeat	  expansions	  (4),	  have	  been	  identified.	  The	  remaining	  5-­‐10%	  of	  cases	  are	  familial	  (FALS)	  and	  are	  
predominantly	  associated	  with	  Mendelian-­‐inherited	  mutations	  in	  Cu/Zn	  superoxide	  dismutase	  (SOD1),	  
TAR-­‐DNA	  binding	  protein	  43	  (TDP-­‐43),	  fused	  in	  sarcoma/	  translocated	  in	  liposarcoma	  (FUS/TLS),	  
C9ORF72,	  and	  other	  genes	  (reviewed	  in	  (3)).	  	  	  
Despite	  the	  profusion	  of	  functionally	  diverse	  genes	  implicated	  in	  FALS	  and	  SALS,	  clinical	  and	  pathological	  
similarities	  between	  all	  forms	  of	  ALS	  suggest	  the	  existence	  of	  a	  common	  pathogenic	  pathway	  that	  could	  
be	  united	  by	  a	  single	  gene/protein	  (5).	  	  One	  of	  the	  mechanisms	  by	  which	  a	  mutant	  or	  wild-­‐type	  (Wt)	  
protein	  can	  dominate	  pathogenesis	  of	  phenotypically	  diverse	  diseases	  is	  by	  propagated	  protein	  
misfolding,	  such	  as	  that	  underpinning	  the	  prion	  diseases,	  which	  has	  been	  increasingly	  implicated	  in	  
other	  neurodegenerative	  and	  systemic	  disorders	  (6,	  7).	  A	  role	  for	  propagated	  protein	  misfolding	  in	  ALS	  is	  
supported	  by	  the	  prion-­‐like	  spatiotemporal	  progression	  of	  disease	  through	  the	  neuroaxis	  (8,	  9).	  
However,	  given	  the	  disparity	  in	  protein	  inclusion	  pathology	  between	  subtypes	  of	  ALS,	  a	  single	  unifying	  
prion-­‐like	  protein	  that	  could	  explain	  such	  a	  progression	  remains	  obscure.	  	  
While	  it	  is	  generally	  accepted	  SOD1	  is	  not	  found	  in	  large	  perikaryal	  cytoplasmic	  inclusions	  outside	  of	  
SOD1	  FALS	  cases,	  misfolded	  SOD1	  has	  been	  increasingly	  identified	  in	  SALS	  and	  non-­‐SOD1	  FALS	  (5,	  10,	  
11).	  	  Indeed,	  we	  have	  reported	  that	  misfolded	  HuWtSOD1	  can	  be	  detected	  by	  spinal	  cord	  
immunohistochemistry	  in	  FALS	  secondary	  to	  FUS	  mutation,	  and	  in	  SALS	  patients	  with	  cytosolic	  TDP-­‐43	  
accumulation	  (11).	  Moreover,	  in	  cell	  models,	  over-­‐expression	  of	  WtTDP-­‐43,	  or	  expression	  of	  mutant	  FUS	  
or	  TDP-­‐43,	  is	  associated	  with	  HuWtSOD1	  misfolding	  (11).	  Collectively,	  these	  data	  are	  consistent	  with	  
SOD1	  being	  a	  “molecular	  common	  denominator”	  for	  all	  types	  of	  ALS.	  Furthermore,	  prion-­‐like	  activity	  has	  
been	  described	  for	  the	  cell-­‐to-­‐cell	  transmission	  of	  misfolding	  of	  mutant	  SOD1	  (12),	  and	  we	  have	  
reported	  that	  mutant	  SOD1	  can	  confer	  its	  misfold	  on	  HuWtSOD1	  (13).	  However,	  mutant	  SOD1	  cannot	  
explain	  propagation	  in	  SALS.	  
In	  order	  to	  test	  if	  HuWtSOD1	  participates	  in	  cell-­‐to-­‐cell	  transmission	  of	  protein	  misfolding,	  we	  make	  use	  
of	  previously	  developed	  mouse	  monoclonal	  antibody	  probes	  for	  misfolded/oxidized	  SOD1,	  recognizing	  
either	  full-­‐length	  human	  mutant	  or	  wild-­‐type	  SOD1	  (HuWtSOD1),	  generated	  against	  regions	  that	  are	  
antibody-­‐inaccessible	  in	  natively	  folded	  SOD1	  (13-­‐15).	  Misfolded	  SOD1	  mAbs	  employed	  in	  this	  work	  are	  
10E11C11	  and	  3H1,	  directed	  against	  an	  unstructured	  electrostatic	  loop	  (disease-­‐specific	  epitope-­‐2;	  
DSE2),	  and	  10C12,	  directed	  against	  a	  C-­‐terminal	  dimer	  interface	  peptide	  in	  which	  the	  cysteine	  at	  
position	  146	  is	  substituted	  by	  a	  cysteic	  acid	  residue	  to	  mimic	  oxidation	  of	  this	  residue	  (DSE1a;	  (13)).	  The	  
use	  of	  such	  antibody	  probes	  have	  enabled	  us	  to	  unambiguously	  determine	  the	  role	  of	  misfolded	  mutant	  
G127X	  in	  the	  induced	  misfolding	  of	  HuWtSOD1,	  which	  upon	  misfolding	  acquires	  a	  marked	  increase	  in	  
sensitivity	  to	  protease	  digestion,	  consistent	  with	  global	  loosening	  of	  structure	  (13).	  	  The	  finding	  that	  
5	  
	  
misfolded	  endogenous	  HuWtSOD1	  was	  observed	  long	  after	  transfected	  G127X-­‐SOD1	  was	  degraded	  
suggested	  that	  HuWtSOD1,	  once	  misfolded,	  is	  capable	  of	  triggering	  an	  intracellular	  propagated	  
misfolding	  reaction	  (13).	  We	  now	  report	  for	  the	  first	  time	  that	  misfolded	  HuWtSOD1	  can	  transit	  cell-­‐to-­‐
cell	  both	  via	  exosomes,	  and	  release	  of	  protein	  aggregates	  and	  subsequent	  uptake	  in	  neuronal	  cells.	  In	  
addition,	  misfolded	  HuWtSOD1	  can	  sustain	  intercellular	  propagated	  misfolding	  in	  vitro	  and	  is	  detectable	  
in	  the	  spinal	  cord	  of	  all	  ALS	  patients	  tested,	  regardless	  of	  the	  genetic	  etiology	  of	  the	  disease.	  	  
Collectively,	  these	  data	  indicate	  that	  HuWtSOD1	  is	  competent	  to	  participate	  in	  propagated	  misfolding,	  
suggesting	  a	  common	  pathogenic	  mechanism	  linking	  FALS	  and	  SALS.	  
Results	  
Cellular	  import	  and	  export	  of	  the	  SOD1	  transmission	  particle	  
Previous	  work	  would	  suggest	  that	  the	  release	  of	  misfolded	  proteins	  is	  likely	  to	  occur	  either	  through	  
exocytosis	  or	  cell	  rupture	  due	  to	  death	  (16)	  while	  uptake	  is	  thought	  to	  be	  non-­‐specific	  and	  mediated	  by	  
fluid	  phase	  endocytosis	  (12).	  	  Mutant	  and	  HuWtSOD1	  have	  been	  shown	  to	  be	  exported	  from	  NSC-­‐34	  
cells	  via	  small	  vesicles	  known	  as	  exosomes	  (17),	  and	  a	  separate	  study	  shows	  that	  protein-­‐only	  
aggregates	  of	  mutant	  SOD1	  are	  efficiently	  imported	  into	  mouse	  N2a	  cells	  by	  a	  macropinocytosis-­‐
dependent	  process	  (12).	  To	  more	  fully	  characterize	  possible	  intercellular	  transmission	  pathways	  of	  SOD1	  
misfolding	  we	  employed	  the	  murine	  motor	  neuron-­‐like	  NSC-­‐34	  cell	  line	  (18).	  	  NSC-­‐34	  cells	  were	  
transfected	  with	  HuWtSOD1-­‐GFP	  or	  mutant	  SOD1-­‐GFP	  variants;	  significant	  cell	  death	  was	  observed	  72	  
hours	  post-­‐transfection	  that	  was	  not	  prominent	  in	  transient	  GFP-­‐alone	  transfection	  or	  in	  SOD1-­‐GFP	  
stably	  transfected	  models	  (Fig.	  1A).	  SOD1-­‐GFP	  aggregates	  are	  observed	  in	  transiently	  transfected	  NSC-­‐
34	  cells,	  but	  not	  in	  stably-­‐transfected	  ones	  (Fig.	  S1).	  	  Taken	  together,	  these	  data	  demonstrate	  the	  
neuron-­‐like	  susceptibility	  of	  NSC-­‐34	  cells	  to	  neurotoxic	  species	  of	  SOD1	  (19).	  	  At	  this	  time-­‐point	  SOD1-­‐
GFP	  positive	  particles,	  both	  HuWt	  and	  mutants,	  could	  be	  transferred	  to	  naïve	  cells	  via	  conditioned	  
medium	  transfer	  and	  uptake	  of	  these	  particles	  could	  be	  detected	  in	  naïve	  NSC-­‐34	  cells	  (Fig.	  1B).	  	  This	  
uptake	  appeared	  specific	  as	  GFP	  by	  itself	  was	  not	  detected	  inside	  naïve	  cells.	  	  Given	  that	  the	  transmitted	  
particle	  may	  be	  a	  complex	  mix	  of	  both	  released	  exosomes	  and	  protein	  aggregates,	  the	  conditioned	  
medium	  was	  analyzed	  by	  immunoblot	  to	  determine	  if	  SOD1	  aggregates	  were	  released	  from	  the	  dying	  
NSC-­‐34	  cells,	  revealing	  SDS-­‐resistant	  oligomers	  released	  by	  cells	  transfected	  with	  SOD1-­‐GFP	  variants,	  
including	  HuWtSOD1	  (Fig.	  1C).	  	  Filter	  trap	  analysis	  confirmed	  aggregates	  larger	  than	  the	  0.2	  μm	  pore	  size	  
in	  conditioned	  medium	  supernatants	  from	  dying	  NSC-­‐34	  cells	  transfected	  with	  all	  SOD1-­‐GFP	  variants	  
(Fig.	  1D,	  E),	  including	  HuWtSOD1-­‐GFP.	  	  To	  determine	  if	  non-­‐vesicular	  protein-­‐only	  SOD1	  aggregates	  can	  
be	  taken	  up	  by	  naïve	  NSC-­‐34	  cells,	  recombinant	  HuWtSOD1	  protein	  was	  firstly	  pre-­‐aggregated	  by	  a	  
seeding	  event	  initiated	  by	  mutant	  misfolded	  G93A	  SOD1	  (Fig.	  S2A-­‐D).	  	  Flow	  cytometry	  with	  confocal	  
microscopy	  demonstrated	  that	  aggregated	  HuWtSOD1	  is	  incorporated	  by	  NSC-­‐34	  cells	  (Fig.	  1F,	  S2E),	  and	  
that	  this	  process	  is	  mediated	  by	  macropinocytosis,	  as	  the	  specific	  inhibitor	  5-­‐(N-­‐ethyl-­‐N-­‐isopropyl)-­‐
amiloride	  (EIPA),	  but	  not	  the	  clathrin-­‐coated	  pit	  inhibitor	  chlorpromazine	  hydrochloride	  (CPZ),	  the	  
caveolin-­‐dependent	  inhibitor	  genestein,	  or	  lipid	  raft	  pathway	  inhibitor	  methyl-­‐β-­‐cyclodextrin	  (MβCD),	  
suppressed	  aggregated	  HuWtSOD1	  uptake	  (Fig.	  S2F).	  	  Furthermore,	  uptake	  is	  SOD1-­‐specific	  and	  
aggregated	  forms	  are	  taken	  up	  as	  efficiently	  as	  non-­‐aggregated	  forms,	  while	  the	  control	  protein,	  GST,	  
was	  not	  taken	  up	  at	  all.	  (Fig.	  S2G).	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Although	  our	  transiently	  transfected	  model	  indicates	  that	  large	  aggregates	  of	  misfolded	  SOD1	  from	  dead	  
or	  dying	  cells	  can	  be	  efficiently	  taken	  up	  by	  neigbouring	  cells,	  we	  and	  others	  have	  found	  that	  exosomal-­‐
mediated	  transport	  is	  relevant	  for	  misfolded	  protein	  transmission	  in	  living	  cells	  (17,	  20),	  for	  which	  we	  
utilized	  stably	  transfected	  NSC-­‐34	  cells	  that	  show	  little	  cell	  death	  (Fig.	  1A).	  Exosomal	  fractions	  were	  
isolated	  from	  these	  cells	  as	  previously	  described	  (17),	  with	  an	  additional	  high-­‐speed	  (100,000	  x	  g)	  
centrifugation	  step	  included	  following	  washing	  to	  ensure	  microvesicles	  are	  sufficiently	  depleted	  of	  non-­‐
specific	  material.	  	  Visualization	  of	  ultracentrifuged	  pellets	  from	  conditioned	  medium	  collected	  from	  
cultures	  of	  stably	  transfected	  NSC-­‐34	  cells	  revealed	  microvesicles	  that	  were	  membrane-­‐bounded,	  
consistent	  with	  exosomes	  in	  morphology	  and	  size	  of	  ~100	  nm	  (Fig.	  1G).	  	  Exosome	  pellets	  showed	  
enrichment	  of	  TSG101	  and	  flotillin	  1	  compared	  to	  cell	  lysates	  confirming	  their	  endosomal	  origin	  (Fig.	  
S3A)	  and	  the	  presence	  of	  PrP	  on	  the	  membrane	  surface	  by	  immunoelectron	  microscopy,	  another	  marker	  
of	  exosomes	  (Fig.	  S3B).	  Immunoelectron	  microscopy	  with	  the	  3H1	  SOD1	  misfolding-­‐specific	  antibody	  
revealed	  that	  ~80-­‐90%	  of	  grains	  were	  associated	  with	  the	  exterior	  of	  exosomes	  secreted	  by	  cells	  stably	  
expressing	  mutant	  or	  HuWtSOD1	  (Fig.	  1H),	  with	  only	  a	  small	  minority	  labeling	  apparent	  protein	  
aggregates	  not	  in	  proximity	  to	  exosomes	  (Fig.	  1I).	  Immunoelectron	  microscopy	  of	  HuWtSOD1-­‐GFP	  
exosomes	  also	  revealed	  robust	  immunoreactivity	  for	  the	  C-­‐terminal	  misfolded/oxidized	  SOD1	  mAb	  
10C12	  (Fig.	  S3C),	  but	  not	  the	  C4F6	  mAb	  directed	  at	  more	  N-­‐terminal	  residues	  80-­‐118	  (5)	  (Fig.	  S3D),	  
implying	  that	  the	  C-­‐terminal	  third	  of	  SOD1	  is	  preferentially	  exposed	  on	  the	  outside	  surface	  of	  exosomes.	  	  
The	  configuration	  of	  misfolded	  SOD1	  associated	  with	  the	  surface	  of	  exosomes	  was	  not	  an	  artifact	  of	  the	  
GFP	  tag	  as	  3H1	  also	  labeled	  non-­‐tagged	  mutant	  or	  HuWtSOD1	  exosomes	  from	  stably	  transfected	  NSC-­‐34	  
cells	  (Fig.	  S3E).	  Flow	  cytometry	  and	  confocal	  microscopy	  of	  naïve	  NSC-­‐34	  cells	  exposed	  to	  exosomes	  
secreted	  from	  cells	  stably	  expressing	  HuWtSOD1-­‐GFP	  revealed	  that	  exosome	  uptake	  was	  relatively	  
efficient	  (Fig.	  1J,	  S3F).	  
HuWtSOD1	  misfolding	  can	  be	  transmitted	  intercellularly	  
Aggregation	  of	  soluble	  intracellular	  mutant	  SOD1	  has	  been	  observed	  upon	  media	  exposure	  to	  the	  same	  
mutants	  in	  an	  aggregated	  state	  (12),	  and	  we	  have	  shown	  that	  mutant	  SOD1	  induces	  the	  misfolding	  of	  
HuWtSOD1	  when	  transfected	  in	  human,	  but	  not	  mouse,	  cell	  lines	  (13).	  	  Furthermore,	  we	  show	  that	  
misfolded	  SOD1,	  both	  wild-­‐type	  and	  mutant,	  may	  be	  exported	  from	  cells	  either	  associated	  with	  
exosomes	  or	  as	  protein-­‐only	  aggregates.	  Thus,	  we	  investigated	  whether	  cells	  containing	  mutant-­‐induced	  
misfolded	  HuWtSOD1	  acquire	  the	  capacity	  to	  transmit	  misfolded	  SOD1	  from	  cell-­‐to-­‐cell,	  and	  whether	  
such	  misfolded	  protein	  could	  act	  as	  propagating	  seeds	  in	  untransfected	  naïve	  cell	  cultures	  (schematically	  
shown	  in	  Fig.	  S4A).	  	  We	  selected	  the	  mesenchymal	  HEK293	  cell	  line	  for	  their	  expression	  of	  substrate	  
HuWtSOD1,	  their	  resistance	  to	  the	  toxicity	  of	  misfolded	  SOD1,	  and	  their	  efficiency	  of	  transfection	  (13).	  	  
DSE-­‐immunoprecipitable	  misfolded	  HuWtSOD1	  was	  detected	  in	  lysates	  of	  HEK293	  cells	  incubated	  
overnight	  with	  conditioned	  media	  from	  HEK293	  cells	  transiently	  transfected	  with	  G127X	  mutant	  SOD1,	  
but	  not	  from	  lysates	  in	  which	  cells	  were	  incubated	  with	  media	  from	  a	  control	  empty	  vector	  transfection	  
(Fig.	  2A,	  S4B),	  reminiscent	  of	  the	  transfer	  observed	  in	  NSC-­‐34	  cells	  (Fig.	  1B).	  	  Incubation	  of	  naïve	  HEK293	  
cells	  with	  media	  from	  cultures	  transiently	  transfected	  with	  green	  fluorescent	  protein	  (GFP)	  did	  not	  
induce	  SOD1	  misfolding	  (Fig	  S4C),	  demonstrating	  that	  the	  misfolding	  of	  HuWtSOD1	  in	  human	  recipient	  
cells	  is	  specifically	  induced	  by	  a	  conditioned	  medium	  factor	  from	  SOD1-­‐transfected	  HEK293	  cells.	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Misfolded	  SOD1	  content	  in	  recipient	  culture	  lysates	  was	  unaffected	  by	  DNase	  digestion	  of	  conditioned	  
media	  (Fig.	  S4D),	  ruling	  out	  a	  contribution	  of	  residual	  transfection	  plasmid.	  Consistent	  with	  prion-­‐like	  
propagated	  misfolding	  of	  HuWtSOD1,	  SOD1	  misfolding	  could	  be	  serially	  passaged	  from	  culture	  to	  culture	  
via	  sequential	  media	  incubation	  (shown	  schematically	  in	  Fig.	  S4A,	  and	  experimentally	  to	  at	  least	  five	  
passages	  in	  Fig.	  2A).	  It	  is	  notable	  that	  from	  the	  first	  passage	  onward,	  the	  DSE-­‐immunoprecipitable	  
misfolded	  SOD1	  in	  lysates	  migrated	  as	  HuWtSOD1,	  despite	  being	  incubated	  with	  supernatants	  of	  cells	  
transfected	  with	  the	  faster-­‐migrating	  SOD1	  mutants	  G127X	  and	  G85R,	  suggesting	  that	  misfolded	  
HuWtSOD1	  was	  competent	  to	  transmit	  its	  acquired	  conformation	  between	  cell	  cultures	  (Fig.	  2A,	  S4E).	  	  
Forced	  over-­‐expression	  of	  HuWtSOD1	  in	  the	  initial	  transfection	  HEK293	  cultures	  (associated	  with	  SOD1	  
misfolding	  (13,	  21))	  also	  resulted	  in	  efficient	  transmission	  of	  SOD1	  misfolding	  via	  media,	  which	  did	  not	  
diminish	  with	  multiple	  serial	  passage	  (Fig.	  2A),	  indicating	  that	  HuWtSOD1	  was	  indeed	  fully	  competent	  to	  
support	  misfolding	  propagation	  in	  a	  self-­‐sustaining	  reaction.	  	  To	  confirm	  the	  capacity	  of	  HuWtSOD1	  to	  
mediate	  prion-­‐like	  propagated	  misfolding	  transmission	  between	  cells,	  we	  depleted	  endogenous	  
HuWtSOD1	  expression	  in	  HEK293	  cells	  with	  siRNA	  oligonucleotides	  prior	  to	  exposure	  to	  conditioned	  
media.	  SOD1-­‐DSE	  immunoprecipitations	  of	  lysates	  from	  HuWtSOD1-­‐depleted	  cells	  revealed	  drastically	  
reduced	  misfolded	  HuWtSOD1	  compared	  to	  control	  incubations	  (Fig.	  2B,	  S5A),	  arguing	  against	  the	  
observed	  misfolded	  HuWtSOD1	  resulting	  solely	  from	  SOD1	  uptake	  from	  conditioned	  media,	  and	  
consistent	  with	  recipient	  cell	  endogenous	  HuWtSOD1	  being	  an	  authentic	  substrate	  for	  propagated	  
protein	  misfolding.	  	  We	  also	  observed	  transmission	  of	  propagated	  SOD1	  misfolding	  to	  primary	  neural	  
cultures	  derived	  from	  embryonic	  mouse	  spinal	  cord	  expressing	  HuWtSOD1	  when	  exogenously	  applied	  
mutant	  misfolded	  SOD1	  in	  conditioned	  medium	  is	  present	  (Fig.	  2C;	  Fig.	  S5B),	  confirming	  that	  the	  process	  
occurs	  in	  a	  physiologically	  relevant	  system.	  
Intercellular	  transmission	  is	  mediated	  by	  particles	  displaying	  misfolded	  SOD1	  
The	  majority	  of	  DSE-­‐immunoprecipitable	  SOD1	  was	  detectable	  in	  the	  ultracentrifuged	  pellets	  of	  
conditioned	  media	  from	  mutant	  SOD1	  transfected	  cells	  (Fig.	  3A).	  Naïve	  cells	  were	  incubated	  with	  re-­‐
suspended	  pellet	  or	  supernatant	  fractions	  of	  ultracentrifuged	  (100,000	  g	  X	  1hr)	  conditioned	  media	  
obtained	  from	  cells	  transfected	  with	  mutant	  or	  wild-­‐type	  constructs	  of	  SOD1.	  Lysates	  from	  incubated	  
cells	  revealed	  that	  ~80%	  of	  the	  HuWtSOD1	  misfolding	  activity	  was	  present	  in	  the	  pellet	  fraction	  (Fig.	  
S6A),	  consistent	  with	  a	  relatively	  massive	  “transmission	  particle”	  composed	  of	  protein-­‐only	  aggregates,	  
associated	  with	  exosomes,	  or	  both.	  Surface	  plasmon	  resonance	  analysis	  of	  pellet	  fractions	  derived	  from	  
conditioned	  media	  revealed	  3H1-­‐immunoreactive	  misfolded	  SOD1	  ,	  even	  in	  G127X-­‐transfected	  
supernatants	  (Fig.	  3B),	  signifying	  the	  extracellular	  presence	  of	  misfolded	  full-­‐length	  SOD1,	  and	  
consistent	  with	  exposed	  misfolded	  HuWtSOD1	  being	  a	  component	  of	  the	  transmission	  particle.	  	  In	  the	  
special	  case	  of	  G127X,	  for	  which	  we	  have	  generated	  a	  mutant-­‐specific	  rabbit	  polyclonal	  antibody	  (13),	  
we	  detected	  limited	  G127X	  protein	  in	  G127X-­‐transfected	  HEK293	  supernatants	  (Fig.	  S6B),	  suggesting	  
that	  on	  first	  transmission	  mutant	  SOD1	  may	  participate	  in	  the	  cell-­‐to-­‐cell	  propagation	  of	  SOD1	  
misfolding.	  However,	  sequential	  dilution	  of	  mutant	  SOD1	  in	  subsequent	  passages	  would	  militate	  against	  
mutant	  SOD1	  being	  an	  essential	  component	  of	  the	  intercellular	  transmission	  particle,	  and	  indeed	  in	  
serial	  passages	  kindled	  by	  transfection	  by	  HuWtSOD1	  (Fig.	  2A),	  mutant	  SOD1	  formally	  cannot	  
participate.	  Exposure	  of	  misfolded	  SOD1	  epitopes	  in	  the	  transmission	  particle	  suggests	  that	  cell-­‐to-­‐cell	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transmission	  might	  be	  neutralized	  by	  antibodies	  directed	  against	  misfolded	  or	  native	  HuWtSOD1.	  
Following	  the	  blocking	  protocol	  schematically	  shown	  in	  Fig.	  S4A,	  the	  HuWtSOD1	  converting	  activity	  of	  
conditioned	  media	  from	  G127X-­‐	  or	  G85R-­‐transfected	  HEK293	  cells	  was	  abolished	  by	  pre-­‐incubation	  with	  
SOD1-­‐specific	  polyclonal	  rabbit	  IgG,	  but	  not	  control	  rabbit	  IgG	  (Fig.	  4A,	  B).	  Furthermore,	  HuWtSOD1	  
conversion	  in	  naïve	  HEK293	  cells	  exposed	  to	  the	  conditioned	  medium	  of	  HEK293	  cells	  transfected	  with	  
G127X,	  G85R	  or	  HuWtSOD1	  was	  attenuated	  by	  DSE	  mAbs	  3H1	  and	  10C12	  expected	  to	  react	  with	  full-­‐
length	  misfolded/oxidized	  isoforms	  of	  SOD1	  (Fig.	  4A-­‐C),	  in	  keeping	  with	  misfolded	  HuWtSOD1	  being	  an	  
accessible	  and	  essential	  component	  of	  the	  cell-­‐to-­‐cell	  transmission	  particle.	  
Aggregates	  of	  misfolded	  HuWtSOD1	  are	  present	  in	  ALS	  patient	  spinal	  cords	  	  
Using	  the	  DSE	  mAbs,	  we	  have	  previously	  demonstrated	  the	  presence	  of	  misfolded/oxidized	  SOD1	  by	  
immunohistochemistry	  (IHC)	  in	  SOD1-­‐	  and	  FUS-­‐FALS,	  and	  in	  SALS	  with	  cytoplasmic	  TDP43	  accumulation	  
(11).	  	  To	  confirm	  the	  presence	  of	  misfolded	  HuWtSOD1	  in	  ALS	  pathology	  in	  vivo,	  we	  examined	  a	  larger	  
series	  of	  IHC	  of	  post-­‐mortem	  human	  spinal	  cord	  sections	  from	  control,	  mutant-­‐SOD1	  FALS,	  non-­‐SOD1	  
FALS	  (including	  two	  cases	  due	  to	  expansion	  mutations	  in	  the	  C9ORF72	  gene	  (22,	  23)),	  and	  SALS	  patients	  
(including	  one	  case	  of	  C9ORF72	  expansion	  without	  family	  history	  of	  ALS;	  Table	  S1).	  In	  all	  cases	  of	  ALS	  
examined,	  regardless	  of	  SOD1	  sequence,	  we	  detected	  immunoreactivity	  with	  the	  DSE	  mAbs	  within	  
motor	  neurons	  (N=28;	  Fig.	  5A-­‐F).	  	  Similar	  types	  of	  structures	  were	  stained	  by	  the	  DSE	  mAbs	  in	  all	  ALS	  
tissue	  samples,	  although	  there	  were	  appreciable	  differences	  in	  distribution	  (Table	  S2),	  with	  mutant	  
SOD1-­‐FALS	  showing	  numerous	  neuronal	  cytoplasmic	  inclusions	  that	  were	  rare	  in	  SALS	  and	  C9ORF72-­‐
FALS,	  in	  addition	  to	  axonal	  and	  tract	  immunoreactivity	  observed	  in	  all	  types	  of	  ALS.	  	  However,	  IHC	  may	  
not	  accurately	  represent	  the	  total	  amount	  of	  misfolded	  SOD1,	  likely	  missing	  soluble	  monomers	  or	  
oligomers	  immunoreactive	  with	  the	  DSE	  mAbs.	  	  We	  thus	  performed	  quantitative	  immunoprecipitation	  
(IP)	  from	  unfixed	  spinal	  cord	  homogenates	  with	  DSE	  mAbs,	  normalized	  to	  total	  SOD1	  
immunoprecipitated	  with	  a	  pan-­‐SOD1	  polyclonal	  antibody	  (pAb).	  	  IP	  experiments	  were	  conducted	  using	  
homogenates	  of	  post-­‐mortem	  cervical	  or	  thoracic	  spinal	  cord	  from	  patients	  with	  mutant-­‐SOD1	  FALS	  and	  
non-­‐SOD1	  SALS	  (including	  one	  case	  with	  C9ORF72	  expansion	  without	  family	  history;	  Fig.	  5G;	  ‘SALS	  2,	  C’),	  
as	  well	  as	  controls	  (Fig.	  5G;	  Table	  S3).	  	  Spinal	  cords	  from	  Alzheimer’s	  disease	  (AD)	  patients	  (N=3)	  were	  
included	  as	  a	  neurological	  disease	  control,	  along	  with	  age-­‐	  and	  sex-­‐matched	  control	  spinal	  cord	  samples	  
from	  normal	  subjects	  (N=4).	  	  Misfolded/oxidized	  SOD1	  was	  detected	  in	  unexpectedly	  high	  concentration	  
of	  ~4%	  in	  SOD1-­‐FALS,	  and	  SALS,	  including	  one	  case	  of	  C9ORF72	  mutation	  without	  family	  history	  of	  ALS	  
(Fig.	  5G,	  S7A).	  	  The	  amount	  of	  SOD1	  immunoprecipitated	  by	  the	  DSE	  mAbs	  was	  not	  significantly	  above	  
background	  in	  either	  AD	  or	  other	  control	  samples.	  
Similar	  to	  our	  previous	  demonstration	  of	  acquisition	  of	  protease	  sensitivity	  by	  induced	  misfolding	  in	  
vitro	  (13),	  we	  found	  that	  that	  DSE-­‐immunoreactive	  SOD1	  species	  in	  vivo	  acquired	  profound	  sensitivity	  to	  
protease	  digestion	  when	  we	  subjected	  FALS	  and	  SALS	  spinal	  cord	  homogenates	  to	  proteinase	  K	  (PK)	  
digestion	  at	  a	  concentration	  of	  200	  μg/ml	  (Fig.	  5G).	  PK	  treatment	  significantly	  decreased	  DSE-­‐
immunoprecipitable	  SOD1	  by	  85-­‐90%	  for	  FALS	  and	  SALS	  for	  both	  DSE	  antibodies	  (Fig.	  S7A).	  	  Titrated	  PK-­‐
digestion	  of	  control	  homogenates	  reveals	  that	  native	  HuWtSOD1	  is	  highly	  resistant	  to	  PK	  digestion,	  even	  
at	  concentrations	  100-­‐fold	  higher	  (Fig.	  S7B).	  	  Detergent-­‐insoluble	  oligomers	  of	  similar	  intensity	  are	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observed	  in	  spinal	  cord	  homogenate	  from	  both	  FALS	  and	  SALS	  patients,	  in	  contrast	  to	  control	  and	  AD	  
samples	  (Fig.	  S7C,	  D);	  similar	  observations	  have	  been	  made	  in	  SOD1	  mouse	  models	  of	  ALS	  (24).	  	  
Discussion	  
Increasing	  evidence	  supports	  the	  notion	  that	  progression	  of	  pathology	  in	  neurodegenerative	  diseases	  
such	  as	  Alzheimer’s	  disease,	  Parkinson’s	  disease,	  tauopathies	  and	  Huntington’s	  disease	  is	  a	  result	  of	  
propagation	  of	  misfolded	  or	  aggregated	  proteins	  (6,	  7,	  16).	  The	  capability	  of	  a	  pathogenic	  protein	  
conformation	  to	  self-­‐propagate	  is	  the	  central	  tenant	  of	  the	  prion	  hypothesis,	  with	  a	  necessary	  
requirement	  of	  sporadic	  prion	  diseases	  being	  that	  the	  process	  of	  conformational	  conversion	  must	  be	  
capable	  of	  being	  mediated	  by	  the	  un-­‐mutated,	  wild-­‐type	  PrP.	  Mutant	  SOD1	  has	  been	  shown	  to	  confer	  its	  
misfolded	  aggregated	  phenotype	  on	  soluble	  mutant	  SOD1	  (12).	  Until	  this	  report,	  unambiguous	  evidence	  
of	  the	  competence	  of	  HuWtSOD1	  in	  propagated	  protein	  misfolding	  has	  been	  lacking.	  We	  and	  others	  
detect	  SOD1	  misfolding	  in	  SALS	  and	  non-­‐SOD1	  FALS,	  in	  addition	  to	  SOD1	  FALS	  (5,	  10)	  and	  here	  we	  
present	  data	  that	  indicates	  that	  misfolded	  and	  protease-­‐sensitive	  HuWtSOD1	  is	  present	  in	  the	  spinal	  
cord	  of	  SALS	  patients,	  representing	  ~	  4%	  of	  total	  SOD1.	  	  Although	  we	  cannot	  rule	  out	  the	  possibility	  that	  
SOD1	  misfolding	  is	  a	  consequence	  of	  SALS	  pathology,	  taken	  together,	  these	  data	  suggest	  propagated	  
misfolding	  of	  SOD1	  is	  a	  strong	  candidate	  for	  a	  downstream	  “final	  common	  pathway”	  for	  all	  types	  of	  ALS,	  
including	  its	  sporadic	  form.	  	  	  
We	  report	  here	  that	  HuWtSOD1	  efficiently	  propagates	  from	  cell-­‐to-­‐cell	  in	  a	  HuWtSOD1	  expression-­‐
dependent	  process	  by	  two	  non-­‐exclusive	  mechanisms:	  release	  of	  protein-­‐only	  aggregates	  and	  cell	  
derived	  vesicles	  identified	  as	  exosomes.	  It	  might	  be	  expected	  that	  aggregates	  of	  “naked”	  misfolded	  
SOD1	  might	  be	  exported	  from	  cells	  as	  they	  die.	  Fibrils	  of	  SOD1	  have	  already	  been	  shown	  to	  be	  a	  
competent	  seed	  for	  further	  SOD1	  aggregation	  in	  vitro	  (25),	  and	  when	  exogenously	  applied	  can	  be	  
efficiently	  taken	  up	  into	  living	  cells	  (26).	  	  In	  addition,	  aggregates	  of	  mutant	  SOD1	  have	  been	  observed	  to	  
be	  taken	  up	  into	  neuron-­‐like	  cells	  via	  macropinocytosis	  (12).	  In	  both	  cases	  the	  multimeric	  structures	  of	  
SOD1	  provide	  competent	  seeds	  for	  aggregation	  of	  soluble	  mutant	  SOD1,	  suggesting	  SOD1	  aggregates	  to	  
be	  an	  efficient	  means	  of	  misfolding	  propagation	  between	  cells.	  Our	  data	  also	  indicates	  that	  
macropinocytosis	  is	  implicated	  in	  the	  uptake	  of	  aggregated	  HuWtSOD1,	  also	  known	  to	  be	  involved	  in	  the	  
propagation	  of	  mutant	  SOD1	  aggregation	  (12).	  	  Although	  we	  have	  not	  identified	  the	  receptors	  involved	  
in	  this	  process	  our	  previous	  work	  on	  microglia	  would	  suggest	  a	  large	  receptor	  complex	  involving	  
scavenger	  or	  other	  pattern	  recognition	  receptors	  and	  signaling	  receptors	  may	  be	  participating	  (27).	  
Heparin	  sulphate	  proteoglycans	  have	  been	  shown	  to	  be	  involved	  in	  aggregate	  uptake	  of	  tau,	  alpha-­‐
synuclein	  and	  prion	  protein	  (28,	  29),	  and	  it	  is	  interesting	  to	  speculate	  that	  this	  family	  of	  receptors	  could	  
be	  involved	  here.	  	  However,	  before	  cell	  death	  ensues	  in	  ALS	  or	  other	  neurodegenerative	  diseases,	  
pathology	  can	  spread	  from	  cell-­‐to-­‐cell	  and	  region	  to	  region	  (8),	  suggesting	  another	  mechanism	  that	  may	  
be	  more	  relevant	  to	  early	  stages	  of	  the	  disease.	  We	  	  propose	  that	  export	  and	  uptake	  may	  be	  mediated	  
by	  a	  pathological	  hijacking	  of	  exosome	  biology,	  which	  has	  been	  theorized	  to	  participate	  in	  prion	  
propagation,	  and	  other	  proteopathic	  neurodegenerative	  diseases	  such	  as	  Alzheimer’s	  and	  Parkinson’s	  
disease	  (reviewed	  in	  (30)).	  	  Exosomes	  can	  interact	  with	  neighbouring	  cells	  by	  various	  mechanisms,	  
including	  direct	  fusion	  with	  recipient	  plasma	  membrane,	  endocytosis	  and	  fusion	  with	  endosomal	  
membrane,	  receptor-­‐mediated	  endocytosis	  and	  phagocytosis	  (31).	  	  Most	  recently,	  exosome	  uptake	  by	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macropinocytosis	  was	  found	  (32)	  which	  could	  lead	  to	  release	  of	  exosomal	  SOD1	  and	  propagation-­‐
competent	  seeds	  delivered	  into	  the	  cytosol	  of	  a	  neighboring	  cell.	  	  	  
Importantly,	  the	  cell-­‐to-­‐cell	  transmission	  of	  SOD1	  misfolding	  can	  be	  neutralized	  with	  antibodies	  directed	  
against	  misfolded	  SOD1,	  which	  is	  consistent	  with	  either	  naked	  aggregate	  transfer,	  or	  transfer	  via	  the	  
antibody-­‐accessible	  surface	  of	  exosomes.	  	  Indeed,	  prion	  or	  amyloid-­‐β	  containing	  exosomes	  are	  not	  
limited	  by	  the	  interior	  release	  of	  misfolded	  or	  aggregated	  protein	  or	  peptides.	  	  Most	  significantly,	  the	  
inhibition	  of	  propagated	  misfolding	  of	  SOD1	  by	  misfolding-­‐specific	  antibodies	  in	  vitro	  suggests	  a	  novel	  
immunotherapeutic	  approach	  to	  neutralizing	  the	  spread	  of	  disease	  in	  ALS	  patients.	  We	  note	  that	  in	  vitro	  
neutralization	  apparently	  correlates	  with	  exosome	  exposure	  of	  misfolding-­‐specific	  epitopes	  3H1	  and	  
10C12;	  however,	  an	  antibody	  directed	  against	  an	  epitope	  not	  exposed	  on	  the	  surface	  of	  exosomes,	  
C4F6,	  is	  not	  effective	  in	  treatment	  of	  mouse	  models	  of	  ALS	  (33).	  	  Thus,	  restrictions	  may	  exist	  on	  
exposure	  of	  the	  cognate	  epitopes	  in	  vivo,	  due	  to	  aggregation	  sequestration	  or	  topological	  constraints	  of	  
misfolded	  SOD1	  on	  exosome	  membranes.	  It	  may	  prove	  important	  to	  understand	  the	  immunological	  
anatomy	  of	  misfolded	  SOD1	  to	  generate	  effective	  immunotherapies	  for	  ALS.	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Materials	  and	  Methods	  
Electron	  microscopy.	  	  Exosomes	  were	  fixed	  in	  2%	  PFA	  in	  PBS	  for	  10	  min	  and	  applied	  to	  glow-­‐discharged	  
200	  mesh	  Cu	  grids	  coated	  with	  formvar-­‐carbon	  film	  (ProSciTech,	  Kirwin,	  Australia)	  and	  absorbed	  for	  20	  
min.	  Grids	  were	  washed	  twice	  (PBS,	  3	  min)	  and	  blocked	  with	  5%	  (w/v)	  BSA	  in	  PBS	  for	  15	  min	  followed	  by	  
staining	  with	  3H1	  (1:200),	  10C12	  (1:200)	  or	  C4F6	  (1:50)	  in	  PBS,	  0.1%	  BSA	  for	  30	  min.	  Grids	  were	  washed	  
6	  times	  and	  incubated	  with	  Aurion	  Protein-­‐G	  gold	  10nm	  (ProSciTech)	  in	  PBS	  for	  90	  min.	  	  Grids	  were	  
washed,	  post-­‐fixed	  with	  2%	  glutaraldehyde	  in	  PBS	  for	  10	  min,	  washed	  again,	  contrasted	  with	  1.5%	  
uranyl	  acetate	  and	  viewed	  with	  a	  300kV	  Tecnai	  G2	  F30	  electron	  microscope	  (FEI).	  	  Exosomal	  and	  
proximate	  free	  3H1-­‐positive	  grains	  were	  counted	  from	  5	  micrographs	  per	  cell	  line	  and	  expressed	  as	  %	  of	  
total	  3H1-­‐positive	  grains.	  
Release	  of	  SOD1	  aggregates.	  	  NSC-­‐34	  cells	  were	  transfected	  with	  HuWtSOD1-­‐GFP,	  G127X	  SOD1-­‐GFP,	  
G93A	  SOD1-­‐GFP	  or	  A4V	  SOD1-­‐GFP.	  After	  72	  hours	  the	  conditioned	  media	  was	  collected	  as	  above	  and	  50	  
µg	  of	  total	  protein	  was	  then	  analyzed	  by	  filter	  trap	  assay	  or	  western	  blot.	  The	  filter	  trap	  assay	  was	  
performed	  as	  previously	  reported	  (34).	  Any	  trapped	  SOD1-­‐GFP	  material	  was	  measured	  using	  an	  anti-­‐GFP	  
antibody.	  Conditioned	  media	  was	  centrifuged	  at	  13,000	  x	  g	  on	  a	  benchtop	  microfuge	  for	  30	  min	  and	  
pellets	  resuspended	  in	  PBS.	  Pelleted	  material	  was	  then	  added	  on	  to	  naïve	  NSC-­‐34	  cells	  and	  incubated	  for	  
60	  minutes	  at	  37oC.	  The	  cells	  were	  then	  fixed	  and	  permeabilized	  and	  internalized	  SOD1-­‐GFP	  was	  
measured	  using	  flow	  cytometry	  (BD	  LSR	  II;	  BD	  Biosciences,	  Franklin	  Lakes,	  NJ).	  
Immunoprecipitation.	  	  Immunoprecipitation	  of	  cell	  lysate	  and	  preparation	  of	  antibody-­‐coupled	  beads	  
were	  performed	  as	  previously	  described	  (13).	  	  Following	  IP	  incubation,	  beads	  were	  washed	  three	  times	  
with	  150	  µl	  PBS	  with	  brief	  vortexing	  in	  between	  washes	  and	  boiled	  in	  SDS	  sample	  buffer.	  	  Samples	  were	  
loaded	  onto	  15%	  acrylamide	  Tris-­‐glycine	  gels	  and	  separated	  by	  SDS-­‐PAGE,	  followed	  by	  immunoblotting.	  	  
Immunoblotting,	  detection	  and	  quantification	  were	  performed	  as	  previously	  described	  (13).	  




NRC	  is	  the	  Canada	  Research	  Chair	  in	  Neurodegeneration	  and	  Protein	  Misfolding	  Diseases	  at	  the	  
University	  of	  British	  Columbia,	  and	  is	  supported	  by	  donations	  from	  the	  Webster	  Foundation,	  the	  Allen	  T.	  
Lambert	  Neural	  Research	  Fund	  and	  the	  Temerty	  Family	  Foundation,	  and	  also	  by	  grants	  from	  PrioNet	  
Canada,	  the	  Canadian	  Institutes	  of	  Health	  Research	  (CIHR),	  and	  Biogen-­‐Idec	  Corp.	  JJY	  is	  supported	  by	  the	  
MND	  Research	  Institute	  of	  Australia	  and	  by	  NHMRC	  project	  grant	  1003032.	  BJT	  is	  supported	  by	  NHMRC	  
Project	  Grant	  1008910	  and	  MND	  Research	  Institute	  of	  Australia	  Mick	  Rodger	  Benalla	  MND	  Research	  
Grant.	  	  AFH	  is	  an	  Australian	  Research	  Council	  Future	  Fellow	  (FT3)	  and	  supported	  by	  an	  NHMRC	  Program	  
Grant	  628946.	  Proprietary	  antibodies	  against	  misfolded	  SOD1	  and	  additional	  funding	  were	  provided	  by	  
Amorfix	  Life	  Sciences.	  	  NRC	  declares	  that	  he	  is	  Founder,	  Chief	  Scientific	  Officer	  and	  Chairman	  of	  Amorfix	  
Life	  Sciences.	  	  




1.	   Armon	  C	  (2007)	  Sports	  and	  trauma	  in	  amyotrophic	  lateral	  sclerosis	  revisited.	  J	  Neurol	  Sci	  262(1-­‐
2):45-­‐53.	  
2.	   Hardiman	  O,	  van	  den	  Berg	  LH,	  &	  Kiernan	  MC	  (2011)	  Clinical	  diagnosis	  and	  management	  of	  
amyotrophic	  lateral	  sclerosis.	  Nat	  Rev	  Neurol	  7(11):639-­‐649.	  
3.	   Robberecht	  W	  &	  Philips	  T	  (2013)	  The	  changing	  scene	  of	  amyotrophic	  lateral	  sclerosis.	  Nat	  Rev	  
Neurosci	  14(4):248-­‐264.	  
4.	   Elden	  AC,	  et	  al.	  (2010)	  Ataxin-­‐2	  intermediate-­‐length	  polyglutamine	  expansions	  are	  associated	  
with	  increased	  risk	  for	  ALS.	  Nature	  466(7310):1069-­‐1075.	  
5.	   Bosco	  DA,	  et	  al.	  (2010)	  Wild-­‐type	  and	  mutant	  SOD1	  share	  an	  aberrant	  conformation	  and	  a	  
common	  pathogenic	  pathway	  in	  ALS.	  Nat	  Neurosci	  13(11):1396-­‐1403.	  
6.	   Guest	  WC,	  et	  al.	  (2011)	  Generalization	  of	  the	  prion	  hypothesis	  to	  other	  neurodegenerative	  
diseases:	  an	  imperfect	  fit.	  J	  Toxicol	  Environ	  Health	  A	  74(22-­‐24):1433-­‐1459.	  
7.	   Prusiner	  SB	  (2012)	  Cell	  biology.	  A	  unifying	  role	  for	  prions	  in	  neurodegenerative	  diseases.	  Science	  
336(6088):1511-­‐1513.	  
8.	   Ravits	  JM	  &	  La	  Spada	  AR	  (2009)	  ALS	  motor	  phenotype	  heterogeneity,	  focality,	  and	  spread:	  
deconstructing	  motor	  neuron	  degeneration.	  Neurology	  73(10):805-­‐811.	  
9.	   Polymenidou	  M	  &	  Cleveland	  DW	  (2011)	  The	  seeds	  of	  neurodegeneration:	  prion-­‐like	  spreading	  in	  
ALS.	  Cell	  147(3):498-­‐508.	  
10.	   Forsberg	  K,	  et	  al.	  (2010)	  Novel	  antibodies	  reveal	  inclusions	  containing	  non-­‐native	  SOD1	  in	  
sporadic	  ALS	  patients.	  PLoS	  ONE	  5(7):e11552.	  
11.	   Pokrishevsky	  E,	  et	  al.	  (2012)	  Aberrant	  localization	  of	  FUS	  and	  TDP43	  is	  associated	  with	  
misfolding	  of	  SOD1	  in	  amyotrophic	  lateral	  sclerosis.	  PLoS	  ONE	  7(4):e35050.	  
12.	   Munch	  C,	  O'Brien	  J,	  &	  Bertolotti	  A	  (2011)	  Prion-­‐like	  propagation	  of	  mutant	  superoxide	  
dismutase-­‐1	  misfolding	  in	  neuronal	  cells.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  108(9):3548-­‐3553.	  
13.	   Grad	  LI,	  et	  al.	  (2011)	  Intermolecular	  transmission	  of	  superoxide	  dismutase	  1	  misfolding	  in	  living	  
cells.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  108(39):16398-­‐16403.	  
14.	   Rakhit	  R,	  et	  al.	  (2007)	  An	  immunological	  epitope	  selective	  for	  pathological	  monomer-­‐misfolded	  
SOD1	  in	  ALS.	  Nat	  Med	  13(6):754-­‐759.	  
15.	   Vande	  Velde	  C,	  Miller	  TM,	  Cashman	  NR,	  &	  Cleveland	  DW	  (2008)	  Selective	  association	  of	  
misfolded	  ALS-­‐linked	  mutant	  SOD1	  with	  the	  cytoplasmic	  face	  of	  mitochondria.	  Proc	  Natl	  Acad	  
Sci	  U	  S	  A	  105(10):4022-­‐4027.	  
16.	   Brundin	  P,	  Melki	  R,	  &	  Kopito	  R	  (2010)	  Prion-­‐like	  transmission	  of	  protein	  aggregates	  in	  
neurodegenerative	  diseases.	  Nat	  Rev	  Mol	  Cell	  Biol	  11(4):301-­‐307.	  
17.	   Gomes	  C,	  Keller	  S,	  Altevogt	  P,	  &	  Costa	  J	  (2007)	  Evidence	  for	  secretion	  of	  Cu,Zn	  superoxide	  
dismutase	  via	  exosomes	  from	  a	  cell	  model	  of	  amyotrophic	  lateral	  sclerosis.	  Neurosci	  Lett	  
428(1):43-­‐46.	  
18.	   Cashman	  NR,	  et	  al.	  (1992)	  Neuroblastoma	  x	  spinal	  cord	  (NSC)	  hybrid	  cell	  lines	  resemble	  
developing	  motor	  neurons.	  Dev	  Dyn	  194(3):209-­‐221.	  
19.	   Gomes	  C,	  et	  al.	  (2008)	  Establishment	  of	  a	  cell	  model	  of	  ALS	  disease:	  Golgi	  apparatus	  disruption	  
occurs	  independently	  from	  apoptosis.	  Biotechnol	  Lett	  30(4):603-­‐610.	  
20.	   Bellingham	  SA,	  Guo	  BB,	  Coleman	  BM,	  &	  Hill	  AF	  (2012)	  Exosomes:	  vehicles	  for	  the	  transfer	  of	  
toxic	  proteins	  associated	  with	  neurodegenerative	  diseases?	  Front	  Physiol	  3:124.	  
21.	   Graffmo	  KS,	  et	  al.	  (2013)	  Expression	  of	  wild-­‐type	  human	  superoxide	  dismutase-­‐1	  in	  mice	  causes	  
amyotrophic	  lateral	  sclerosis.	  Hum	  Mol	  Genet	  22(1):51-­‐60.	  
22.	   DeJesus-­‐Hernandez	  M,	  et	  al.	  (2011)	  Expanded	  GGGGCC	  hexanucleotide	  repeat	  in	  noncoding	  
region	  of	  C9ORF72	  causes	  chromosome	  9p-­‐linked	  FTD	  and	  ALS.	  Neuron	  72(2):245-­‐256.	  
14	  
	  
23.	   Renton	  AE,	  et	  al.	  (2011)	  A	  hexanucleotide	  repeat	  expansion	  in	  C9ORF72	  is	  the	  cause	  of	  
chromosome	  9p21-­‐linked	  ALS-­‐FTD.	  Neuron	  72(2):257-­‐268.	  
24.	   Furukawa	  Y,	  Fu	  R,	  Deng	  HX,	  Siddique	  T,	  &	  O'Halloran	  TV	  (2006)	  Disulfide	  cross-­‐linked	  protein	  
represents	  a	  significant	  fraction	  of	  ALS-­‐associated	  Cu,	  Zn-­‐superoxide	  dismutase	  aggregates	  in	  
spinal	  cords	  of	  model	  mice.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  103(18):7148-­‐7153.	  
25.	   Chia	  R,	  et	  al.	  (2010)	  Superoxide	  dismutase	  1	  and	  tgSOD1	  mouse	  spinal	  cord	  seed	  fibrils,	  
suggesting	  a	  propagative	  cell	  death	  mechanism	  in	  amyotrophic	  lateral	  sclerosis.	  PLoS	  ONE	  
5(5):e10627.	  
26.	   Furukawa	  Y,	  Kaneko	  K,	  Watanabe	  S,	  Yamanaka	  K,	  &	  Nukina	  N	  (2013)	  Intracellular	  seeded	  
aggregation	  of	  mutant	  Cu,Zn-­‐superoxide	  dismutase	  associated	  with	  amyotrophic	  lateral	  
sclerosis.	  FEBS	  Lett	  587(16):2500-­‐2505.	  
27.	   Roberts	  K,	  et	  al.	  (2013)	  Extracellular	  aggregated	  Cu/Zn	  superoxide	  dismutase	  activates	  microglia	  
to	  give	  a	  cytotoxic	  phenotype.	  Glia	  61(3):409-­‐419.	  
28.	   Horonchik	  L,	  et	  al.	  (2005)	  Heparan	  sulfate	  is	  a	  cellular	  receptor	  for	  purified	  infectious	  prions.	  J	  
Biol	  Chem	  280(17):17062-­‐17067.	  
29.	   Holmes	  BB,	  et	  al.	  (2013)	  Heparan	  sulfate	  proteoglycans	  mediate	  internalization	  and	  propagation	  
of	  specific	  proteopathic	  seeds.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  110(33):E3138-­‐3147.	  
30.	   Vella	  LJ,	  Sharples	  RA,	  Nisbet	  RM,	  Cappai	  R,	  &	  Hill	  AF	  (2008)	  The	  role	  of	  exosomes	  in	  the	  
processing	  of	  proteins	  associated	  with	  neurodegenerative	  diseases.	  Eur	  Biophys	  J	  37(3):323-­‐332.	  
31.	   Thery	  C,	  Ostrowski	  M,	  &	  Segura	  E	  (2009)	  Membrane	  vesicles	  as	  conveyors	  of	  immune	  responses.	  
Nat	  Rev	  Immunol	  9(8):581-­‐593.	  
32.	   Fitzner	  D,	  et	  al.	  (2011)	  Selective	  transfer	  of	  exosomes	  from	  oligodendrocytes	  to	  microglia	  by	  
macropinocytosis.	  J	  Cell	  Sci	  124(Pt	  3):447-­‐458.	  
33.	   Gros-­‐Louis	  F,	  Soucy	  G,	  Lariviere	  R,	  &	  Julien	  JP	  (2010)	  Intracerebroventricular	  infusion	  of	  
monoclonal	  antibody	  or	  its	  derived	  Fab	  fragment	  against	  misfolded	  forms	  of	  SOD1	  mutant	  
delays	  mortality	  in	  a	  mouse	  model	  of	  ALS.	  J	  Neurochem	  113(5):1188-­‐1199.	  
34.	   Matsumoto	  G,	  Stojanovic	  A,	  Holmberg	  CI,	  Kim	  S,	  &	  Morimoto	  RI	  (2005)	  Structural	  properties	  and	  
neuronal	  toxicity	  of	  amyotrophic	  lateral	  sclerosis-­‐associated	  Cu/Zn	  superoxide	  dismutase	  1	  
aggregates.	  J	  Cell	  Biol	  171(1):75-­‐85.	  
	  
	  




Figure	  1.	  	  Aggregated	  SOD1	  is	  released	  from	  dead	  or	  dying	  cells	  and/or	  actively	  released	  as	  part	  of	  
exosomes.	  (A)	  Cell	  death	  of	  GFP-­‐positive	  cells	  after	  72	  hours	  post-­‐transfection	  was	  examined	  by	  flow	  
cytometry.	  Cells	  stained	  with	  PI	  were	  scored	  as	  dead	  and	  these	  cells	  expressed	  as	  a	  proportion	  of	  total	  
GFP	  positive	  cells.	  The	  results	  are	  means	  and	  standard	  error	  of	  three	  independent	  experiments.	  (B)	  
Uptake	  of	  pelletable	  SOD1-­‐GFP	  by	  naïve	  NSC-­‐34	  cells	  following	  incubation	  with	  conditioned	  media	  was	  
measured	  by	  flow	  cytometry.	  The	  data	  shown	  is	  calculated	  from	  triplicate	  experiments.	  Error	  bars	  
represent	  SEM	  and	  *	  indicates	  statistical	  significance	  (P	  <	  0.05)	  compared	  to	  medium	  from	  non-­‐
transfected	  (NT)	  cells,	  as	  determine	  by	  unpaired	  t-­‐test.	  	  (C)	  Detection	  of	  oligomeric	  SOD1	  released	  into	  
media	  72	  hours	  post-­‐transfection.	  	  White	  arrow	  indicates	  SOD1-­‐GFP	  monomer	  while	  black	  arrow	  
indicates	  SOD1-­‐GFP	  dimer.	  Area	  indicated	  by	  *	  represents	  SDS-­‐resistant	  oligomeric	  SOD1	  species.	  
Immunoblot	  probed	  with	  GFP	  polyclonal	  antibody.	  (D)	  Filter-­‐trap	  assay	  and	  anti-­‐GFP	  immunoblot	  to	  
detect	  SOD1-­‐GFP	  aggregates	  in	  conditioned	  media.	  The	  filter	  trap	  was	  performed	  in	  triplicate	  and	  is	  
quantified	  in	  (E).	  	  Values	  obtained	  from	  the	  filter	  trap	  assay	  are	  the	  mean	  average	  of	  three	  independent	  
experiments.	  Error	  bars	  represent	  SEM.	  	  *,	  denotes	  P	  <	  0.05	  compared	  to	  negative	  controls	  (NT	  and	  
EGFP).	  	  (F)	  	  Quantitative	  analysis	  of	  aggregated	  human	  SOD1	  internalization	  into	  NSC-­‐34	  cells	  using	  flow	  
cytometry.	  Cells	  were	  either	  incubated	  with	  PBS	  (grey)	  or	  aggregated	  HuWtSOD1	  (red	  line).	  	  (G)	  
Visualization	  of	  exosomes	  secreted	  by	  NSC-­‐34	  cells	  by	  negative	  staining	  electron	  microscopy	  (scale	  bar	  =	  
100nm).	  	  (H)	  Immunogold	  labeling	  using	  3H1	  antibody	  shows	  surface	  localized	  misfolded	  SOD1	  on	  
exosomes	  secreted	  by	  stably	  transfected	  NSC-­‐34	  cells	  (scale	  bar	  =	  50nm).	  	  (I)	  Quantification	  of	  exosomal	  
and	  proximal	  free	  misfolded	  SOD1	  secreted	  by	  NSC-­‐34	  cells.	  	  (J)	  NSC-­‐34	  cells	  were	  treated	  with	  NSC-­‐34-­‐
derived	  exosomes	  for	  30	  min	  and	  fixed.	  Quantitative	  analysis	  of	  SOD1-­‐GFP	  internalization	  into	  NSC-­‐34	  
cells	  using	  flow	  cytometry.	  Cells	  were	  either	  incubated	  with	  PBS	  (grey)	  or	  HuWtSOD1-­‐GFP	  exosomes	  
(red	  line).	  	  	  
Figure	  2.	  	  Mutant	  SOD1-­‐mediated	  HuWtSOD1	  misfolding	  is	  transmissible	  between	  cells.	  (A)	  
Immunoprecipitation	  (IP)	  of	  lysates	  from	  naïve	  HEK	  cells	  cultured	  in	  the	  presence	  of	  conditioned	  
medium	  from	  one,	  three	  and	  five	  passages	  of	  transduction	  assays	  initiated	  by	  different	  SOD1	  variants.	  
mIgG2a,	  mouse	  IgG2a	  isotype	  control;	  rIgG,	  rabbit	  mixed	  IgG	  control;	  SOD1,	  pan-­‐SOD1	  antibody;	  3H1	  
and	  10C12,	  misfolded	  SOD1	  specific	  antibodies.	  	  (B)	  SOD1	  knockdown	  abolishes	  detectable	  misfolding.	  	  
IP	  of	  lysates	  from	  HEK	  cells	  with	  knocked-­‐down	  SOD1	  expression	  cultured	  in	  the	  presence	  of	  conditioned	  
medium	  from	  HEK	  cells	  transfected	  with	  empty	  vector	  control	  (EV),	  SOD1-­‐G85R,	  SOD1-­‐G127X,	  or	  
HuWtSOD1.	  	  (C)	  	  IP	  of	  lysates	  from	  naïve	  primary	  neural	  cell	  cultures	  derived	  from	  embryonic	  spinal	  cord	  
of	  HuWtSOD1	  transgenic	  or	  non-­‐transgenic	  littermate	  (n-­‐Tg)	  mice	  incubated	  in	  the	  presence	  of	  
conditioned	  from	  SOD1-­‐G127X-­‐	  or	  empty	  vector	  (EV)-­‐transfected	  HEK293	  cells.	  
Figure	  3.	  	  Misfolded	  SOD1	  is	  detectable	  in	  the	  culture	  media	  of	  cells	  transfected	  with	  SOD1	  constructs.	  	  
(A)	  Misfolded	  SOD1	  was	  detected	  by	  IP	  in	  both	  the	  pellet	  (P)	  and	  supernatant	  (S)	  fractions	  of	  
centrifugated	  conditioned	  media,	  but	  majority	  was	  detected	  in	  the	  P	  fraction.	  C-­‐less	  GX,	  cysteine-­‐less	  
version	  of	  G127X	  SOD1;	  mIgG2a,	  mouse	  IgG2a	  isotype	  control;	  rIgG,	  rabbit	  mixed	  IgG	  control;	  SOD1,	  
pan-­‐SOD1	  antibody;	  3H1	  and	  10C12,	  misfolded	  SOD1	  specific	  antibodies.	  This	  was	  confirmed	  by	  Biacore	  
detection	  of	  misfolded	  SOD1	  in	  the	  pellet	  fraction	  by	  3H1	  capture	  (B).	  	  Values	  represent	  the	  average	  of	  
16	  
	  
seven	  independent	  experiments.	  *,	  indicates	  significant	  values.	  	  Statistical	  significance	  determined	  by	  
unpaired	  t-­‐test,	  compared	  to	  EV	  control	  (significant	  P-­‐values	  shown);	  error	  bars	  give	  standard	  deviation.	  
Figure	  4.	  	  SOD1	  antibodies	  can	  block	  misfolding	  transmission.	  	  IP	  of	  lysates	  from	  naive	  HEK	  cells	  
cultured	  in	  the	  presence	  of	  conditioned	  medium	  from	  G127X-­‐transfected	  HEK	  cells	  (A),	  G85R-­‐
transfected	  HEK	  cells	  (B),	  or	  HuWtSOD1-­‐transfected	  HEK	  cells	  (C)	  immunologically	  pre-­‐treated	  with	  
either	  rabbit	  mixed	  IgG	  (rIgG),	  pan-­‐SOD1	  pAb	  (SOD1),	  or	  DSE	  mAbs	  3H1	  or	  10C12,	  all	  at	  20	  μg/ml.	  	  
Corresponding	  quantitation	  is	  shown	  to	  the	  right	  of	  each	  immunoblot.	  	  Values	  represent	  the	  mean	  
average	  of	  four	  independent	  experiments.	  	  Error	  bars	  represent	  standard	  deviation.	  	  *,	  statistically	  
significant	  blocking	  of	  wtSOD1	  misfolding	  transmission	  by	  specific	  antibodies	  as	  determined	  by	  ANOVA	  
analysis	  followed	  by	  Tukey	  (HSD)	  multiple	  comparison.	  	  For	  G127X	  experiment,	  P=0.0048;	  for	  G85R	  
experiment,	  P=0.0100;	  for	  HuWtSOD1	  experiment,	  P=0.032.	  
Figure	  5.	  	  Misfolded	  SOD1	  is	  detectable	  in	  the	  spinal	  cords	  of	  both	  FALS	  and	  SALS	  patients.	  	  
Immunohistochemistry	  using	  antibodies	  against	  misfolded	  SOD1	  in	  cases	  of	  FALS	  with	  SOD1	  mutations	  
(A-­‐D)	  and	  SALS	  (E,	  F).	  In	  cases	  with	  SOD1	  mutations,	  neuronal	  cytoplasmic	  inclusions	  and	  neurites	  
(arrow)	  were	  labeled	  in	  the	  primary	  motor	  cortex	  (A)	  and	  ventral	  grey	  matter	  of	  the	  spinal	  cord	  (B,	  C).	  
The	  spinal	  grey	  matter	  (d)	  also	  contained	  numerous	  swollen	  axons.	  Immunopositive	  axons	  of	  normal	  
calibre	  with	  a	  visible	  myelin	  sheath	  were	  present	  in	  the	  corticospinal	  tracts	  (arrows,	  E)	  and	  motor	  nerve	  
roots	  (arrows,	  F)	  in	  sporadic	  cases.	  	  Immunohistochemistry	  using	  10E11C11	  (A,	  B,	  D-­‐F)	  and	  3H1	  (C)	  
antibodies.	  	  Scale	  bar:	  20	  µm,	  A	  and	  D;	  30	  µm	  B	  and	  C;	  12	  µm	  E	  and	  F.	  (G)	  Immunoprecipitation	  of	  10%	  
(w/v)	  spinal	  cord	  homogenate	  in	  PBS	  using	  DSE	  mAbs,	  normalized	  to	  equal	  concentrations	  of	  SOD1.	  	  
Samples	  were	  pre-­‐incubated	  at	  37°C	  for	  30	  min	  in	  the	  presence	  or	  absence	  of	  200	  µg/ml	  proteinase	  K	  










SI	  Materials	  and	  Methods	  
Cell	  culture	  and	  transfection.	  	  Cell	  culturing	  and	  transfections	  for	  HEK293FT,	  N2a	  and	  NSC-­‐34	  cell	  lines	  
were	  performed	  as	  described	  (1).	  	  For	  induction	  experiments,	  culture	  medium	  from	  transfected	  
HEK293FT	  cells	  was	  collected	  48	  h	  post-­‐transfection	  followed	  by	  centrifugation	  for	  5	  min	  at	  1000	  x	  g	  to	  
remove	  debris.	  The	  resulting	  supernatant	  was	  placed	  onto	  naive	  HEK	  or	  N2a	  cells,	  supplemented	  with	  
fresh	  growth	  medium,	  and	  incubated	  at	  37˚C	  for	  20	  h.	  	  This	  was	  repeated	  as	  required	  for	  multi-­‐passage	  
transduction.	  To	  assess	  the	  relative	  particle	  size	  of	  the	  misfolding	  agent,	  conditioned	  media	  from	  
transfected	  cells	  was	  collected	  and	  centrifuged	  at	  100,000	  x	  g	  for	  1	  h.	  	  The	  supernatant	  fraction	  was	  
concentrated	  using	  an	  Amicon®	  Ultra-­‐4	  Centrifugal	  Filter	  Unit	  (3-­‐kDa;	  Millipore,	  Billerica,	  MA)	  and	  eluted	  
into	  1	  ml	  of	  PBS;	  the	  pellet	  fraction	  was	  resuspended	  in	  1	  ml	  of	  PBS.	  	  Fractions	  were	  added	  to	  fresh	  
growth	  medium	  and	  cultured	  with	  HEK	  cells	  as	  above.	  	  For	  blocking	  experiments,	  conditioned	  medium	  
was	  pre-­‐incubated	  with	  the	  designated	  antibodies	  at	  a	  concentration	  of	  20	  μg/ml	  for	  30	  min	  at	  37˚C,	  
and	  then	  placed	  on	  naive	  HEK	  cells	  for	  20	  h.	  Cells	  were	  then	  collected	  and	  lysed	  for	  immunoprecipitation	  
as	  described	  below.	  
Mouse	  NSC-­‐34	  cells	  were	  cultured	  in	  Dulbecco's	  modified	  Eagle	  Medium	  with	  10%	  FCS,	  1%	  penicillin-­‐
streptomycin	  and	  1%	  glutamine	  (Invitrogen,	  Carlsbad,	  CA).	  	  Cells	  were	  transiently	  or	  stably	  transfected	  
with	  mutant	  or	  HuWtSOD1-­‐EGFP	  constructs	  (2)	  using	  Lipofectamine	  2000	  (Invitrogen,	  Carlsbad,	  CA).	  
Experiments	  involving	  animals	  were	  conducted	  according	  to	  the	  Canadian	  Council	  on	  Animal	  Care	  
guidelines	  and	  have	  been	  approved	  by	  the	  Animal	  Care	  Committee	  of	  the	  University	  of	  British	  Columbia	  
(Approval	  ID:	  A10-­‐0212).	  Pregnant	  C57	  BL/6	  female	  mice	  (Strain:	  B6SJL-­‐Tg(SOD1)2Gur/J,	  Stock:002297;	  
Jackson	  Laboratories,	  Bar	  Harbor,	  ME)	  were	  sacrificed	  according	  to	  the	  guidelines	  of	  the	  Institutional	  
Animal	  Care	  and	  Use	  Committee	  (IACUC).	  Primary	  cerebral	  cortical	  cultures	  were	  prepared	  from	  12–14	  
day	  fetal	  mice.	  All	  mouse	  tissue	  culture	  reagents	  were	  purchased	  from	  GIBCO	  BRL	  (Grand	  Island,	  NY),	  
except	  where	  noted.	  	  Following	  embryo	  genotyping,	  cervical,	  thoracic	  and	  lumbar-­‐	  regions	  of	  the	  spinal	  
cord	  were	  dissected	  out	  in	  Ca2+	  /Mg2+	  -­‐free	  Hanks	  Balanced	  Salts.	  Meninges	  were	  removed	  and	  the	  
tissue	  was	  transferred	  to	  0.25%	  trypsin	  and	  digested	  at	  37uC	  for	  15	  min.	  Tissue	  was	  then	  resuspended	  in	  
DMEM	  plus	  10%	  fetal	  bovine	  serum	  and	  triturated	  4–6	  times	  through	  a	  fire-­‐polished	  tip.	  The	  
supernatant	  was	  centrifuged	  at	  200	  6g	  for	  45	  sec.	  Pelleted	  neural	  cells	  were	  resuspended	  in	  Neurobasal	  
media,	  B27,	  2	  mM	  L-­‐glutamine	  (Sigma;	  Saint	  Louis,	  MO)	  and	  seeded	  at	  a	  density	  of	  26105	  cells/	  well	  
onto	  poly-­‐D-­‐lysine	  (Sigma)	  coated	  #1.5	  coverslips	  in	  24-­‐well	  plates.	  Cultures	  were	  maintained	  in	  serum-­‐
free	  Neurobasal-­‐B27	  medium,	  and	  one-­‐half	  of	  medium	  was	  replaced	  on	  day	  3	  or	  4	  with	  equal	  volume	  of	  
fresh	  medium.	  Cells	  were	  transfected	  at	  5	  DIV	  using	  Lipofectamine	  LTX	  with	  Plus	  reagent	  (Invitrogen;	  
Carlsbad,	  CA).	  
Confocal	  microscopy.	  	  Wild-­‐type	  or	  mutant	  SOD1-­‐GFP	  was	  expressed	  in	  NSC-­‐34	  cells	  after	  stable	  
transfection	  (as	  described	  (2))	  or	  transient	  transfection	  (Lipofectamine	  2000	  as	  before).	  After	  72	  hours	  
SOD1-­‐GFP	  fluorescence	  was	  imaged	  using	  a	  Leica	  TCS	  SP5	  II	  scanning	  confocal	  microscope	  (Leica	  
Microsystems,	  Wetzlar,	  Germany)	  using	  a	  60x	  objective.	  An	  argon	  laser	  (488	  nm)	  was	  used	  to	  excite	  the	  
GFP	  fusion	  and	  emission	  was	  collected	  at	  520	  +/-­‐	  20	  nm	  using	  a	  standard	  PMT.	  Data	  was	  acquired	  in	  
Leica	  Application	  Suite	  (Leica	  Microsystems).	  	  For	  visualization	  of	  SOD1-­‐GFP	  uptake	  via	  exosomes,	  NSC-­‐
2	  
	  
34	  cells	  (5	  x	  104	  cells/well)	  in	  24-­‐well	  plates	  were	  incubated	  with	  exosomes	  (pooled	  from	  2	  x	  75	  cm2	  
flasks)	  in	  200	  µl	  serum-­‐free	  DMEM	  for	  30	  min	  at	  37°C.	  	  Cells	  were	  fixed	  with	  4%	  (w/v)	  PFA	  in	  PBS,	  
stained	  with	  Hoechst	  33342	  (1:10,000)	  and	  visualised	  using	  an	  Olympus	  FV	  1000	  confocal	  microscope.	  
Cell	  death.	  	  Cells	  were	  removed	  from	  culture	  media,	  resuspended	  in	  PBS	  and	  propidium	  iodide	  was	  
added	  immediately	  before	  analysis	  by	  flow	  cytometry.	  GFP	  positive	  cells	  (em	  515	  nm)	  were	  gated	  and	  
were	  analyzed	  for	  positive	  staining	  with	  propidium	  iodide	  (PI;	  em	  575	  nm).	  Cells	  stained	  with	  PI	  were	  
scored	  as	  dead	  and	  these	  cells	  expressed	  as	  a	  proportion	  of	  total	  GFP	  positive	  cells.	  The	  results	  are	  
means	  and	  standard	  error	  of	  three	  independent	  experiments.	  	  
Aggregation	  of	  recombinant	  SOD1.	  	  SOD1	  was	  incubated	  at	  0.5	  mg/mL	  in	  10	  mM	  potassium	  phosphate	  
buffer	  containing	  10	  mM	  DTT	  and	  5	  mM	  EDTA,	  pH	  7.4	  at	  37oC	  whilst	  shaking.	  	  Aggregation	  was	  
measured	  as	  an	  increase	  in	  thioflavin	  T	  fluorescence.	  	  
Exosome	  isolation.	  	  Cell	  lines	  were	  cultured	  in	  75	  cm2	  flasks	  until	  confluent.	  Medium	  was	  replaced	  with	  
fresh	  15	  ml	  serum-­‐free	  medium	  overnight.	  	  Conditioned	  medium	  was	  sequentially	  centrifuged	  at	  1,000	  g	  
for	  20	  min,	  10,000	  g	  for	  20	  min	  and	  100,000	  g	  for	  1	  hr.	  	  Exosome	  pellets	  were	  washed	  in	  PBS	  by	  
centrifuging	  at	  100,000	  g	  for	  1	  hr	  and	  resuspended	  in	  serum-­‐free	  DMEM.	  	  Naive	  NSC-­‐34	  cells	  
suspensions	  (5	  x	  105	  cells)	  detached	  with	  1	  mM	  EDTA	  were	  treated	  with	  exosomes	  for	  30	  min	  at	  37°C,	  
fixed	  and	  permeabilized,	  and	  internalized	  SOD1-­‐GFP	  measured	  using	  flow	  cytometry.	  
Cell	  surface	  binding	  and	  internalization	  of	  aggregated	  SOD1.	  	  NSC-­‐34	  cells	  were	  initially	  incubated	  with	  
20	  μg/mL	  of	  aggregated	  HuWtSOD1	  for	  30	  min	  at	  4°C.	  Cells	  were	  fixed	  with	  4%	  (w/v)	  PFA	  in	  PBS	  (pH	  7.4)	  
before	  being	  permeabilized	  with	  Triton	  X-­‐100,	  and	  subsequent	  detection	  of	  recombinant	  SOD1	  with	  
sheep	  polyclonal	  anti-­‐human	  SOD1	  or	  using	  streptavidin-­‐Alexa488	  to	  detect	  aggregates	  that	  have	  been	  
biotinylated.	  	  Cells	  were	  quantitatively	  analyzed	  by	  flow	  cytometry	  (BD	  LSR	  II;	  BD	  Biosciences,	  Franklin	  
Lakes,	  NJ).	  	  Internalization	  of	  aggregated	  HuWtSOD1	  was	  confirmed	  using	  confocal	  microscopy	  of	  
treated	  cells	  while	  remaining	  adhered	  to	  a	  coverslip.	  	  Internalisation	  was	  further	  measured	  in	  the	  
presence	  or	  absence	  of	  a	  range	  of	  compounds	  that	  inhibit	  various	  internalization	  mechanisms.	  	  NSC-­‐34	  
cells	  were	  pre-­‐treated	  with	  either	  25	  μg/mL	  cytochalasin	  D,	  5	  μM	  of	  chlorpromazine	  hydrochloride	  
(CPZ),	  100	  μM	  of	  5-­‐ethyl-­‐N-­‐isopropyl	  amiloride	  (EIPA)	  or	  5	  mM	  methyl-­‐β-­‐cyclodextrin	  (MβCD)	  for	  30	  min	  
at	  37°C,	  followed	  by	  20	  μg/mL	  wildtype	  aggregated	  SOD1	  for	  30	  min	  at	  37°C.	  Cells	  were	  then	  incubated	  
with	  4%	  (w/v)	  PFA	  in	  PBS	  (pH	  7.4)	  for	  30	  min	  at	  room	  temperature	  followed	  by	  incubation	  with	  triton	  x-­‐
100	  for	  15	  min.	  Human	  SOD1	  was	  detected	  as	  before.	  
SOD1	  expression	  knock-­‐down.	  	  SOD1	  protein	  levels	  were	  knocked-­‐down	  in	  HEK	  cells	  using	  a	  
combination	  of	  two	  SOD1-­‐specific	  siRNA	  oligonucleotides	  (Cat.	  nos.	  S451,	  S452;	  Invitrogen).	  	  
Transfections	  were	  performed	  using	  Lipofectamine	  RNAiMAX	  (Invitrogen)	  according	  to	  manufacturer’s	  
instructions.	  A	  random	  siRNA	  oligonucleotide	  mixture	  (Invitrogen,	  Cat.	  no.	  4611G)	  served	  as	  a	  negative	  
control.	  	  The	  transfection	  complex	  was	  incubated	  for	  12	  min	  and	  added	  to	  60%	  confluent	  HEK	  cells	  
growing	  in	  10	  ml	  complete	  growth	  media.	  Following	  80	  h	  incubation,	  media	  was	  replaced	  with	  
conditioned	  media	  from	  cells	  transfected	  with	  different	  SOD1	  constructs	  and	  incubated	  for	  an	  additional	  
20	  h.	  Cells	  were	  then	  collected	  and	  lysed	  for	  immunoprecipitation.	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Surface	  plasmon	  resonance	  detection	  of	  misfolded	  SOD1	  in	  transfected	  cell	  media.	  	  HEK	  cells	  were	  
transfected	  as	  described	  above.	  	  48	  h	  post-­‐transfection,	  media	  was	  harvested	  and	  centrifuged	  at	  
100,000	  g	  for	  1	  h.	  	  Following	  centrifugation,	  supernatant	  was	  aspirated	  to	  1ml	  in	  each	  tube	  into	  which	  
the	  pellet	  was	  resuspended	  for	  analysis.	  Measurement	  of	  misfolded	  wtSOD1	  was	  performed	  using	  a	  
BiaCore	  3000	  surface	  plasmon	  resonance	  detector	  (GE	  Healthcare,	  Uppsala,	  Sweden)	  as	  previously	  
described	  (1).	  	  A	  total	  of	  seven	  replicates	  were	  performed	  for	  each	  transfectant.	  
Immunohistochemistry.	  	  All	  spinal	  cord	  tissues	  were	  obtained	  at	  autopsy	  within	  48	  h	  of	  patient	  death.	  	  
Immunohistochemistry	  was	  performed	  on	  cases	  of	  familial	  ALS	  with	  known	  SOD1	  mutations	  (SOD1+	  
FALS,	  N	  =	  5),	  familial	  ALS	  with	  SOD1	  mutations	  excluded	  (SOD1-­‐	  FALS,	  N	  =	  3),	  sporadic	  ALS	  (SALS,	  N	  =	  20)	  
and	  normal	  controls	  (N	  =	  5).	  	  Immunohistochemistry	  was	  performed	  on	  3	  µm	  sections	  of	  formalin-­‐fixed,	  
paraffin-­‐embedded	  tissue	  using	  the	  Ventana	  BenchMark®	  XT	  automated	  staining	  system	  (Ventana	  
Medical	  Systems,	  Inc.,	  Tucson,	  AZ)	  and	  developed	  with	  aminoethylcarbizole	  (AEC).	  	  Optimal	  staining	  was	  
produced	  under	  the	  following	  conditions;	  10E11C11	  (1:500,	  following	  microwave	  pre-­‐treatment),	  3H1	  
(1:50,	  following	  standard	  heat	  retrieval)	  and	  10C12	  (1:10,	  following	  standard	  heat	  retrieval).	  
SOD1	  solubility.	  	  Solubilized	  spinal	  cord	  homogenates	  were	  centrifuged	  for	  8	  min	  at	  100,000	  x	  g	  in	  a	  
TLA100.3	  rotor	  to	  separate	  the	  soluble	  supernatant	  (S)	  from	  the	  crude	  pellet.	  	  Crude	  pellet	  was	  
resolubilized	  and	  centrifuged	  to	  obtain	  the	  non-­‐ionic	  detergent-­‐insoluble	  pellet	  (P).	  	  1	  M	  iodoacetamide	  
was	  added	  to	  the	  S	  and	  P	  fractions	  to	  a	  final	  concentration	  of	  100	  mM.	  	  2X	  SDS	  sample	  buffer	  without	  β-­‐
mercaptoethanol	  (non-­‐reducing	  sample	  buffer)	  was	  added	  to	  1X	  final	  concentration	  and	  separated	  on	  
Novex	  4-­‐20%	  acrylamide	  gels	  (Invitrogen),	  followed	  by	  immunoblotting	  .	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Figure	  S1.	  SOD1	  inclusions	  form	  in	  transiently	  transfected	  cells	  but	  not	  stably	  transfected	  cells.	  
Confocal	  microscopy	  of	  SOD1-­‐EGFP	  stably	  transfected	  or	  transiently	  transfected	  NSC-­‐34	  cells.	  Green	  =	  
SOD1;	  scale	  bar	  =	  50	  μm.	  	  White	  arrows	  indicate	  intracellular	  SOD1	  inclusions	  in	  transiently-­‐transfected	  
cells.	  
Figure	  S2.	  	  Aggregated	  recombinant	  human	  SOD1	  can	  seed	  WT	  SOD1	  aggregation.	  (A)	  Aggregation	  of	  
purified	  recombinant	  HuWt	  and	  G93A	  SOD1	  is	  followed	  in	  real	  time	  using	  Thioflavin	  T	  fluorescence.	  
Under	  the	  conditions	  tested	  (0.5	  mg/mL	  SOD1	  in	  10	  mM	  DTT	  and	  5	  mM	  EDTA),	  HuWtSOD1	  does	  not	  
aggregate.	  (B)	  Pre-­‐aggregated	  mutant	  SOD1	  was	  added	  to	  starting	  solution	  of	  HuWtSOD1,	  to	  give	  10%	  of	  
total	  SOD1,	  to	  induce	  aggregation.	  Only	  in	  the	  presence	  of	  seeds	  does	  substantial	  HuWtSOD1	  
aggregation	  occur.	  (C)	  HuWtSOD1	  aggregates	  taken	  from	  (b)	  were	  added	  to	  starting	  solutions	  of	  
HuWtSOD1	  and	  used	  to	  seed	  further	  aggregation.	  (D)	  Representative	  TEM	  image	  of	  fibrillar	  aggregates	  
formed	  by	  HuWtSOD1.	  Scale	  bar	  represents	  500	  nm.	  (E)	  Aggregated	  SOD1	  is	  internalized	  by	  NSC-­‐34	  
cells.	  	  Biotinylated	  recombinant	  human	  SOD1	  pre-­‐aggregated	  in	  vitro	  was	  exogenously	  applied	  to	  NSC-­‐34	  
cells,	  incubated,	  and	  then	  fixed	  and	  probed	  using	  streptavin-­‐Alexa488.	  	  Confocal	  microscopy	  was	  used	  to	  
examine	  immunofluorescence	  associated	  with	  human	  SOD1	  aggregates.	  	  Scale	  bar	  =	  7.5	  µm.	  (F)	  
Aggregated	  SOD1	  is	  internalized	  via	  macropinocytosis.	  	  Internalization	  of	  aggregated	  HuWtSOD1	  was	  
measured	  by	  flow	  cytometry,	  in	  the	  presence	  or	  absence	  of	  a	  pre-­‐incubation	  step	  with	  cytochalasin	  D,	  
chlorpromazine	  hydrochloride	  (CPZ),	  5-­‐ethyl-­‐N-­‐isopropyl	  amiloride	  (EIPA)	  or	  methyl-­‐β-­‐cyclodextrin	  
(MβCD).	  Error	  bars	  represent	  SEM	  from	  6	  replicates,	  and	  *	  denotes	  statistical	  significance	  determined	  by	  
unpaired	  t-­‐test,	  compared	  to	  no	  inhibitor	  control	  (significant	  P-­‐values	  shown).	  Although	  the	  actin	  
dependent	  pathway	  inhibitor	  cytochalasin	  D	  decreased	  the	  SOD1	  internalized	  into	  the	  NSC-­‐34	  cells,	  this	  
was	  not	  statistically	  significant.	  	  (G)	  SOD1	  is	  specifically	  taken	  up	  by	  neuron-­‐like	  cells.	  NSC-­‐34	  cells	  were	  
incubated	  with	  soluble	  HuWt	  or	  G93A	  SOD1	  or	  aggregated	  recombinant	  SOD1	  protein	  (Agg)	  for	  30	  min.	  
Cells	  were	  then	  fixed/permeabilized	  and	  probed	  for	  human	  SOD1.	  As	  a	  control,	  cells	  were	  incubated	  
under	  the	  same	  conditions	  with	  glutathione-­‐s-­‐transferase	  (GST)	  and	  probed	  for	  GST.	  Error	  bars	  
represent	  geometric	  means	  of	  three	  independent	  experiments.	  
Figure	  S3.	  Characterization	  of	  exosomes	  and	  exosomal	  surface	  misfolded	  SOD1.	  	  (A)	  Immunoblot	  
analysis	  of	  exosomal	  markers	  in	  cell	  and	  exosome	  (exo)	  fractions	  from	  NSC-­‐34	  cells.	  	  (B)	  Immunogold	  
labeling	  of	  surface	  localized	  PrP	  on	  exosomes	  from	  NSC-­‐34	  cells	  by	  electron	  microscopy.	  	  Immunogold	  
labeling	  using	  10C12	  (C),	  but	  not	  C4F6	  (D),	  shows	  surface-­‐localized	  misfolded	  SOD1	  on	  exosomes	  
secreted	  by	  NSC-­‐34	  cells	  stably	  transfected	  with	  mutant	  or	  HuWtSOD1-­‐GFP.	  	  (E)	  Immunogold	  labeling	  
using	  3H1	  antibody	  shows	  presence	  of	  misfolded	  SOD1	  on	  the	  outside	  of	  exosomes	  secreted	  by	  NSC-­‐34	  
cells	  transiently	  transfected	  with	  untagged	  HuWtSOD1	  or	  mutant	  (G93A).	  	  Scale	  bar	  (B-­‐E)	  =	  50	  nm.	  (F)	  
Exosomal	  SOD1	  is	  internalized	  by	  NSC-­‐34	  cells.	  Naive	  NSC-­‐34	  cells	  were	  treated	  with	  exosomes	  derived	  
from	  SOD1-­‐GFP	  stably	  transfected	  NSC-­‐34	  cells	  for	  30	  min,	  fixed	  and	  visualized	  by	  confocal	  microscopy.	  
Scale	  bar	  =	  20	  µm.	  
Figure	  S4.	  	  Controls	  establishing	  specificity	  of	  propagated	  SOD1	  misfolding	  reaction.	  	  (A)	  Template	  
directed	  misfolding	  transduction	  and	  blocking	  (see	  Figure	  4)	  experimental	  design.	  (B)	  Quantitation	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summary	  of	  Fig.	  1d	  with	  values	  represented	  as	  the	  mean	  average	  of	  four	  independent	  experiments.	  
Error	  bars	  represent	  standard	  error.	  	  *,	  statistically	  significant	  induction	  (P	  =	  0.003)	  of	  HuWtSOD1	  
misfolding	  between	  species	  and	  between	  control	  vs.	  G127X	  conditioned	  media	  induction	  as	  determined	  
by	  ANOVA	  analysis	  followed	  by	  Tukey	  (HSD)	  multiple	  comparison.	  (C)	  Exposure	  to	  a	  non-­‐SOD1	  β-­‐barrel	  
protein	  (GFP)	  does	  not	  induce	  HuWtSOD1	  misfolding.	  	  Immunoprecipitation	  of	  lysates	  from	  naïve	  HEK	  
cells	  cultured	  in	  the	  presence	  of	  conditioned	  media	  from	  GFP-­‐transfected	  HEK	  cells.	  	  HuWtSOD1	  
immunoprecipitation	  with	  DSE	  mAbs	  3H1	  and	  10C12	  is	  negligible.	  	  Quantitation	  summary	  is	  included;	  
error	  bars	  represent	  standard	  error.	  	  (D)	  SOD1	  misfolding	  is	  not	  due	  to	  residual	  mutant	  SOD1	  
transfection	  plasmid	  in	  conditioned	  media.	  	  Immunoprecipitation	  of	  lysates	  from	  naïve	  HEK	  cells	  
cultured	  in	  the	  presence	  of	  conditioned	  media	  from	  G127X-­‐transfected	  HEK	  cells,	  pre-­‐incubated	  in	  the	  
presence	  or	  absence	  (PBS	  only)	  of	  1	  unit	  DNase	  I/µg	  of	  transfected	  DNA.	  	  Quantitation	  summary	  is	  
included;	  error	  bars	  represent	  standard	  error.	  (E)	  The	  percentage	  of	  total	  immunoprecipitable	  SOD1	  as	  a	  
function	  of	  the	  number	  of	  misfolded	  SOD1-­‐induced	  transduction	  assay	  passages	  from	  conditioned	  
media	  derived	  from	  four	  different	  SOD1	  construct	  transfections.	  	  Values	  are	  the	  average	  of	  at	  least	  three	  
independent	  experiments.	  	  Error	  bars	  represent	  standard	  deviation.	  	  mIgG2a,	  mouse	  IgG2a	  isotype	  
control;	  rIgG,	  rabbit	  mixed	  IgG	  control;	  	  SOD1,	  pan-­‐SOD1	  antibody;	  	  GX-­‐CT,	  antibody	  against	  non-­‐native	  
C-­‐terminal	  end	  of	  SOD1-­‐G127X;	  3H1	  and	  10C12,	  misfolded	  SOD1	  specific	  antibodies.	  
Figure	  S5.	  	  	  	  Quantitation	  of	  immunoprecipitation	  experiments.	  (A)	  Quantitation	  of	  
immunoprecipitations	  derived	  from	  siRNA	  knockdown	  experiment	  described	  in	  Figure	  2B.	  	  Error	  bars	  
represent	  standard	  error.	  	  Values	  represent	  the	  average	  of	  four	  independent	  experiments.	  	  Error	  bars	  
represent	  standard	  error.	  	  *,	  indicates	  significant	  values.	  	  Statistical	  significance	  determined	  by	  unpaired	  
t-­‐test,	  compared	  to	  controls	  (significant	  P-­‐values	  shown).	  	  mIgG2a,	  mouse	  IgG2a	  isotype	  control;	  rIgG,	  
rabbit	  mixed	  IgG	  control;	  SOD1,	  pan-­‐SOD1	  antibody;	  3H1	  and	  10C12,	  misfolded	  SOD1	  specific	  
antibodies.	  (B)	  Quantitation	  of	  immunoprecipitations	  derived	  from	  SOD1	  transduction	  experiments	  in	  
mouse	  neural	  cultures	  described	  in	  Figure	  2C.	  	  Any	  signal	  detected	  from	  mIgG2a	  isotype	  control	  was	  
deemed	  background	  and	  subtracted	  from	  signal	  from	  SOD1-­‐DSE	  antibody	  pull-­‐down	  of	  misfolded	  SOD1.	  	  
Values	  represent	  the	  average	  of	  three	  independent	  experiments.	  	  Error	  bars	  represent	  standard	  error.	  	  
Statistical	  significance	  determined	  by	  unpaired	  t-­‐test,	  compared	  to	  empty	  vector	  (EV)	  conditioned	  
medium	  controls	  (significant	  P-­‐values	  shown).	  	  	  
Figure	  S6.	  	  Transmission	  of	  misfolded	  SOD1	  occurs	  via	  large	  molecular	  mass	  particles	  that	  are	  exposed	  
to	  DSE	  antibodies.	  	  (A)	  Quantitation	  of	  misfolded	  wtSOD1	  immunoprecipitation	  from	  fractionated	  post-­‐
transfection	  conditioned	  media.	  	  Values	  represent	  the	  mean	  average	  from	  four	  independent	  
experiments.	  	  Error	  bars	  give	  standard	  error.	  	  *	  indicates	  significant	  values;	  statistical	  significance	  was	  
determined	  by	  using	  the	  Mann-­‐Whitney	  test	  to	  compare	  pairs	  of	  soluble	  (S)	  and	  pellet	  (P)	  fractions	  of	  
conditioned	  media	  from	  cell	  transfections	  of	  different	  SOD1	  constructs	  (significant	  P-­‐values	  shown).	  (B)	  
Immunoprecipitation	  of	  concentrated	  culture	  media	  from	  G127X-­‐transfected	  HEK	  cells.	  	  HuWtSOD1	  and	  
G127X	  SOD1	  are	  in	  physical	  association	  with	  one	  another,	  a	  precursor	  to	  intermolecular	  conversion	  of	  
misfolding	  in	  conditioned	  media.	  	  GX-­‐CT	  pAb	  captures	  minimal	  G127X,	  but	  also	  co-­‐immunoprecipitates	  
full-­‐length	  wtSOD1.	  	  Since	  G127X	  in	  which	  all	  cysteine	  residues	  have	  been	  substituted	  with	  serines	  was	  
as	  efficient	  as	  native	  G127X,	  the	  formation	  of	  interchain	  disulfide	  bonds	  was	  not	  essential	  to	  initiate	  the	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propagation	  of	  HuWtSOD1	  misfolding.	  *,	  indicates	  unknown	  SOD1	  degradation	  product	  specific	  to	  
conditioned	  media.	  
Figure	  S7.	  	  Misfolded	  oligomeric	  SOD1	  is	  detectable	  in	  the	  spinal	  cords	  of	  both	  FALS	  and	  SALS	  patients.	  	  
(A)	  Quantitation	  of	  pull-­‐down	  of	  DSE	  mAb	  immunoprecipitable	  SOD1	  expressed	  as	  a	  percentage	  of	  total	  
immunoprecipitable	  SOD1	  pulled	  down	  by	  the	  pan-­‐SOD1	  antibody.	  	  Data	  is	  the	  average	  of	  4	  
independent	  experiments	  for	  each	  patient	  sample;	  results	  for	  each	  patient	  group	  were	  pooled.	  	  Error	  
bars	  represent	  standard	  deviation.	  	  Statistical	  significance	  was	  determined	  using	  Mann-­‐Whitney	  test	  to	  
compare	  pairs	  of	  PK-­‐treated	  vs.	  untreated	  samples	  (significant	  P-­‐values	  shown).	  	  (B)	  2	  µg	  of	  10%	  spinal	  
cord	  homogenate	  diluted	  in	  IP	  buffer	  from	  normal	  patients	  treated	  with	  increasing	  concentrations	  of	  PK.	  	  
SOD1	  from	  normal	  spinal	  cord	  is	  resistant	  to	  PK,	  even	  at	  a	  concentration	  100-­‐fold	  higher	  than	  used	  in	  
experiments	  shown	  in	  (A).	  	  (C)	  Spinal	  cord	  homogenates,	  in	  the	  presence	  of	  1%	  NP-­‐40,	  were	  separated	  
to	  generate	  a	  soluble	  fraction	  (S)	  and	  a	  detergent-­‐insoluble	  pellet	  (P).	  	  The	  S	  and	  P	  fractions,	  denatured	  
in	  sample	  buffer	  without	  a	  reducing	  agent,	  were	  separated	  on	  4-­‐20%	  acrylamide	  gels	  by	  standard	  SDS-­‐
PAGE.	  	  C,	  cervical	  spinal	  cord;	  T,	  thoracic	  spinal	  cord.	  (D)	  Quantitation	  of	  the	  detergent-­‐insoluble	  
oligomers	  (P	  fraction;	  vertical	  bar	  in	  (a)	  represents	  the	  region	  quantified).	  	  Data	  is	  the	  average	  of	  4	  
independent	  experiments	  for	  each	  patient	  sample;	  results	  are	  pooled	  into	  disease	  categories.	  	  Error	  bars	  
represent	  standard	  deviation.	  	  Statistical	  significance	  determined	  by	  unpaired	  t-­‐test,	  compared	  to	  
normal	  controls	  (significant	  P-­‐values	  shown).	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Clinical	  and	  demographical	  information	  on	  spinal	  cord	  tissues	  used	  for	  
immunohistochemistry	  
Disease	  Status	   Mutation	  (Gene)	   Spinal	  Cord	  Region	   Sex	   Age	   Onset	  age	  
Normal	   -­‐	   C,	  L	   M	   35	   -­‐	  
Normal	   -­‐	   C,	  L	   M	   53	   -­‐	  
Normal	   -­‐	   C,	  L	   M	   56	   -­‐	  
Normal	   -­‐	   C,	  L	   M	   63	   -­‐	  
Normal	   -­‐	   C,	  L	   F	   90	   -­‐	  
SOD1+FALS	   A4V	  (SOD1)	   C,	  L	   M	   46	   43	  
SOD1+FALS	   A4V	  (SOD1)	   C,	  L	   M	   52	   50	  
SOD1+FALS	   D90A	  (SOD1)	   C,	  L	   M	   60	   n/a	  
SOD1+FALS	   D90A	  (SOD1)	   C,	  L	   M	   63	   46	  
SOD1+FALS	   G72C	  (SOD1)	   C,	  L	   F	   75	   70	  
SOD1-­‐FALS	   C9ORF72	   C,	  L	   M	   47	   46	  
SOD1-­‐FALS	   C9ORF72	   C,	  L	   M	   56	   55	  
SOD1-­‐FALS	   R521C	  (FUS)	   C,	  L	   F	   64	   63	  
SOD1-­‐SALS	   unknown	   C,	  L	   M	   53	   53	  
SOD1-­‐SALS	   unknown	   C,	  L	   M	   57	   57	  
SOD1-­‐SALS	   unknown	   C,	  L	   M	   64	   63	  
SOD1-­‐SALS	   unknown	   C,	  L	   M	   66	   63	  
SOD1-­‐SALS	   unknown	   C,	  L	   M	   73	   71	  
SOD1-­‐SALS	   unknown	   C,	  L	   M	   77	   76	  
SOD1-­‐SALS	   unknown	   C,	  L	   M	   79	   78	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   43	   n/a	  
SOD1-­‐SALS	   C9ORF72	   C,	  L	   F	   59	   57	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   65	   64	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   65	   64	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   66	   65	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   66	   66	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   66	   65	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   66	   63	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   72	   72	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   73	   72	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   74	   73	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   82	   73	  
SOD1-­‐SALS	   unknown	   C,	  L	   F	   83	   80	  
All	  tissues	  collected	  at	  autopsy	  with	  48	  hours	  of	  patient	  death	  and	  used	  directly	  for	  IHC	  analysis.	  




Relative	  abundance	  of	  antibody	  staining	  in	  various	  regions	  and	  structures	  of	  patient	  spinal	  
cord	  sections	  
10C12	  (DSE1a	  mAb)	  staining	  
Structure/Region	   SOD1	  FALS	   non-­‐SOD	  FALS	  
non-­‐SOD1	  
SALS	   Control	  
Neuronal	  cytoplasmic	  inclusion	   ++	   -­‐	   -­‐	   -­‐	  
Axonal	  swellings	   +	   -­‐	   -­‐	   -­‐	  
Axons	   ++	   +	   +	   -­‐	  
Corticospinal	  tract	   +	   +	   +	   -­‐	  
Other	  tracts	   +	   -­‐	   -­‐	   -­‐	  
Motor	  Roots	   +	   +	   +	   -­‐	  
	  	   	  	   	  	   	  	   	  	  
3H1	  (DSE2	  mAb)	  staining	   	  	   	  	   	  	   	  	  
Structure/Region	   SOD1	  FALS	   non-­‐SOD	  FALS	  
non-­‐SOD1	  
SALS	   Control	  
Neuronal	  cytoplasmic	  inclusion	   ++	   -­‐	   -­‐	   -­‐	  
Axonal	  swellings	   ++	   -­‐	   -­‐	   -­‐	  
Axons	   ++	   +	   +	   -­‐	  
Corticospinal	  tract	   +	   +	   +	   -­‐	  
Other	  tracts	   +	   -­‐	   -­‐	   -­‐	  
Motor	  Roots	   +	   +	   +	   -­‐	  
	  	   	  	   	  	   	  	   	  	  
10E11C11	  (DSE2	  mAb)	  staining	   	  	   	  	   	  	  
Structure/Region	   SOD1	  FALS	   non-­‐SOD	  FALS	  
non-­‐SOD1	  
SALS	   Control	  
Neuronal	  cytoplasmic	  inclusion	   ++	   -­‐	   -­‐	   -­‐	  
Axonal	  swellings	   ++	   -­‐	   -­‐	   -­‐	  
Axons	   +++	   ++	   +	   -­‐	  
Corticospinal	  tract	   +++	   ++	   ++	   -­‐	  
Other	  tracts	   +	   +	   +	   -­‐	  
Motor	  Roots	   ++	   +	   +	   -­‐	  
Grey	  box	  indicates	  sub-­‐structures	  within	  the	  ventral	  grey	  matter.	  Positive	  staining	  in	  corticospinal	  tract,	  




Clinical	  and	  demographical	  data	  on	  frozen	  spinal	  cord	  sections	  
Sample	  ID	   Disease	  status	   Spinal	  Cord	  Region	   Sex	   Age	   PMI	  
Normal	  1	   Normal	   Cervical	   M	   65	   n/a	  
Normal	  2	   Normal	   Cervical	   M	   38	   n/a	  
Normal	  3	   Normal	   Cervical	   M	   55	   n/a	  
Normal	  4	   Normal	   Cervical	   F	   76	   4	  days	  
AD	  1	   Alzheimer's	  Disease	   Cervical	   M	   71	   4	  days	  
AD	  2	   Alzheimer's	  Disease	   Cervical	   M	   68	   4	  days	  
AD	  3	   Alzheimer's	  Disease	   Cervical	   F	   66	   3	  days	  
FALS	  (A4V)	   SOD1	  FALS	  (A4V)	   Cervical	   M	   52	   2	  days	  
FALS	  (G72C)	   SOD1	  FALS	  (G72C)	   Cervical	   F	   75	   2	  days	  
SALS	  C-­‐SC	  1	   non-­‐SOD1	  SALS	   Cervical	   M	   66	   2	  days	  
SALS	  C-­‐SC	  2	   C9ORF72	  SALS	   Cervical	   F	   59	   1	  day	  
SALS	  T-­‐SC	  1	   non-­‐SOD1	  SALS	   Thoracic	   M	   73	   n/a	  
SALS	  T-­‐SC	  2	   nonSOD1	  SALS	   Thoracic	   F	   39	   n/a	  
PMI,	  post-­‐mortem	  interval.	  
	  
